OP Bancorp (OPBK) 10-Q 8 Nov 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 03, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-38437
Entity Registrant Name	OP BANCORP
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	81-3114676
Entity Address, Address Line One	1000 Wilshire Blvd.
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90017
City Area Code	213
Local Phone Number	892-9999
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	OPBK
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		15,133,407
Entity Central Index Key	0001722010
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONSOLIDATED BALANCE SHEETS (un

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 188,145	$ 106,310
Available-for-sale debt securities, at fair value	102,535	91,791
Other investments	11,025	10,101
Loans held-for-sale	94,466	26,659
Loans receivable, net of allowance of $14,134 in 2021 and $15,352 in 2020	1,217,687	1,084,384
Premises and equipment, net	4,199	4,544
Accrued interest receivable, net of allowance of $465 in 2021 and $643 in 2020	3,931	3,985
Servicing assets	12,389	7,360
Company owned life insurance	11,070	10,879
Deferred tax assets	5,247	5,242
Operating right-of-use assets	9,270	6,786
Other assets	19,947	8,785
Total assets	1,679,911	1,366,826
Deposits:
Noninterest bearing	713,141	522,754
Interest bearing:
Money market and others	351,186	328,323
Time deposits greater than $250,000	209,091	200,210
Other time deposits	222,988	148,803
Total deposits	1,496,406	1,200,090
Federal Home Loan Bank advances	0	5,000
Accrued interest payable	575	1,021
Operating lease liabilities	10,703	8,429
Other liabilities	13,603	8,920
Total liabilities	1,521,287	1,223,460
Shareholders’ equity
Preferred stock – no par value; 10,000,000 shares authorized; no shares issued or outstanding in 2021 and 2020	0	0
Common stock – no par value; 50,000,000 shares authorized; 15,133,407 and 15,016,700 shares issued and outstanding in 2021 and 2020	78,718	78,657
Additional paid-in capital	8,491	8,521
Retained earnings	71,436	55,348
Accumulated other comprehensive (loss) income	(21)	840
Total shareholders’ equity	158,624	143,366
Total liabilities and shareholders' equity	$ 1,679,911	$ 1,366,826

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Loans receivable, allowance	$ 14,134	$ 15,352
Accrued interest receivable, allowance	$ 465	$ 643
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares, issued (in shares)	15,133,407	15,016,700
Common stock, shares, outstanding (in shares)	15,133,407	15,016,700

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
INTEREST INCOME
Interest and fees on loans	$ 16,922	$ 12,581	$ 45,177	$ 38,823
Interest on available-for-sale debt securities	269	319	723	920
Other interest income	164	116	436	538
Total interest income	17,355	13,016	46,336	40,281
Interest expense
Interest on deposits	766	1,597	2,406	7,098
Total interest expense	766	1,597	2,406	7,098
Net interest income	16,589	11,419	43,930	33,183
(Reversal of) provision for loan losses	(884)	1,399	(1,376)	4,130
Net interest income after (reversal of) provision for loan losses	17,473	10,020	45,306	29,053
NONINTEREST INCOME
Service charges on deposits	409	334	1,157	1,063
Loan servicing fees, net of amortization	599	583	1,432	1,489
Gain on sale of loans	2,188	1,813	5,280	3,904
Other income	346	291	859	923
Total noninterest income	3,542	3,021	8,728	7,379
NONINTEREST EXPENSE
Salaries and employee benefits	5,724	5,086	15,693	14,505
Occupancy and equipment	1,326	1,266	3,795	3,737
Data processing and communication	448	424	1,363	1,247
Professional fees	308	287	925	836
FDIC insurance and regulatory assessments	146	112	401	334
Promotion and advertising	175	81	528	405
Directors’ fees	183	147	427	603
Foundation donation and other contributions	842	360	1,989	935
Other expenses	367	224	1,153	926
Total noninterest expense	9,519	7,987	26,274	23,528
INCOME BEFORE INCOME TAX EXPENSE	11,496	5,054	27,760	12,904
INCOME TAX EXPENSE	3,246	1,459	8,054	3,594
NET INCOME	$ 8,250	$ 3,595	$ 19,706	$ 9,310
EARNINGS PER SHARE - BASIC (in dollars per share)	$ 0.54	$ 0.23	$ 1.29	$ 0.60
EARNINGS PER SHARE - DILUTED (in dollars per share)	$ 0.54	$ 0.23	$ 1.29	$ 0.60
Other comprehensive (loss)/income:
Change in unrealized (losses)/gains on securities available-for-sale	$ (343)	$ 57	$ (1,222)	$ 1,120
Tax effect	102	(17)	361	(331)
Total other comprehensive (loss)/income	(241)	40	(861)	789
COMPREHENSIVE INCOME	$ 8,009	$ 3,635	$ 18,845	$ 10,099

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (shares) at Dec. 31, 2019		15,703,276
Beginning balance at Dec. 31, 2019	$ 140,576	$ 86,381	$ 7,524	$ 46,483	$ 188
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,310			9,310
Other comprehensive income (loss)	789				789
Stock issued under stock-based compensation plans (shares)		268,591
Stock issued under stock-based compensation plans	305	$ 305
Stock-based compensation, net	858		858
Repurchase of common stock (shares)		(845,597)
Repurchase of common stock	(7,086)	$ (7,086)
Cash dividends declared	(3,203)			(3,203)
Ending balance (shares) at Sep. 30, 2020		15,126,270
Ending balance at Sep. 30, 2020	141,549	$ 79,600	8,382	52,590	977
Beginning balance (shares) at Jun. 30, 2020		15,068,030
Beginning balance at Jun. 30, 2020	139,136	$ 79,925	8,218	50,056	937
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,595			3,595
Other comprehensive income (loss)	40				40
Stock issued under stock-based compensation plans (shares)		116,356
Stock issued under stock-based compensation plans	0	$ 0
Stock-based compensation, net	164		164
Repurchase of common stock (shares)		(58,116)
Repurchase of common stock	(325)	$ (325)
Cash dividends declared	(1,061)			(1,061)
Ending balance (shares) at Sep. 30, 2020		15,126,270
Ending balance at Sep. 30, 2020	141,549	$ 79,600	8,382	52,590	977
Beginning balance (shares) at Dec. 31, 2020		15,016,700
Beginning balance at Dec. 31, 2020	143,366	$ 78,657	8,521	55,348	840
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	19,706			19,706
Other comprehensive income (loss)	(861)				(861)
Stock issued under stock-based compensation plans (shares)		120,537
Stock issued under stock-based compensation plans	89	$ 89
Stock-based compensation, net	(30)		(30)
Repurchase of common stock (shares)		(3,830)
Repurchase of common stock	(28)	$ (28)
Cash dividends declared	(3,618)			(3,618)
Ending balance (shares) at Sep. 30, 2021		15,133,407
Ending balance at Sep. 30, 2021	158,624	$ 78,718	8,491	71,436	(21)
Beginning balance (shares) at Jun. 30, 2021		15,133,407
Beginning balance at Jun. 30, 2021	151,962	$ 78,718	8,324	64,700	220
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,250			8,250
Other comprehensive income (loss)	(241)				(241)
Stock issued under stock-based compensation plans (shares)		0
Stock issued under stock-based compensation plans	0	$ 0
Stock-based compensation, net	167		167
Repurchase of common stock (shares)		0
Repurchase of common stock	0	$ 0
Cash dividends declared	(1,514)			(1,514)
Ending balance (shares) at Sep. 30, 2021		15,133,407
Ending balance at Sep. 30, 2021	$ 158,624	$ 78,718	$ 8,491	$ 71,436	$ (21)

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Stockholders' Equity [Abstract]
Cash dividends declared (in dollars per share)	$ 0.10	$ 0.07	$ 0.24	$ 0.21

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities
Net income	$ 19,706	$ 9,310
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
(Reversal of) provision for loan losses	(1,376)	4,130
Depreciation and amortization of premises and equipment	989	981
Amortization of net premiums on securities	707	337
Amortization of servicing assets	2,448	1,156
Amortization of low-income housing partnerships	405	268
Stock-based compensation	403	965
Deferred income taxes	356	(1,052)
Gain on sales of loans	(5,280)	(3,904)
Earnings on company owned life insurance	(191)	(197)
Net change in fair value of equity investment with readily determinable fair value	73	(89)
Origination of loans held for sale	(123,661)	(98,285)
Proceeds from sales of loans held for sale	59,545	61,457
Net change in:
Accrued interest receivable	631	(1,802)
Other assets	(6,935)	2,878
Accrued interest payable	(446)	(1,331)
Other liabilities	443	(1,008)
Net cash used in by operating activities	(52,183)	(26,186)
Cash flows from investing activities
Net change in loans receivable	(40,761)	(82,621)
Proceeds from matured, called, or paid-down securities available-for-sale	27,118	20,552
Purchase of loans and servicing assets	(97,631)	0
Purchase of securities available-for-sale	(39,791)	(56,703)
Purchase of FHLB stock	(963)	(685)
Purchase of premises and equipment, net	(644)	(511)
Net change in investments in low-income housing partnerships	(636)	(1,262)
Net cash used in investing activities	(153,308)	(121,230)
Cash flows from financing activities
Net change in deposits	296,316	149,453
Cash received from stock option exercises	89	305
Payment of Federal Home Loan Bank advances	(5,000)	0
Proceeds from Federal Home Loan Bank advances	0	10,000
Repurchase of common stock	(28)	(7,086)
Cash dividend paid on common stock	(3,618)	(3,203)
Payments related to tax-withholding for vested restricted stock awards	(433)	(108)
Net cash provided by financing activities	287,326	149,361
Net change in cash and cash equivalents	81,835	1,945
Cash and cash equivalents at beginning of period	106,310	85,943
Cash and cash equivalents at end of period	188,145	87,888
Supplemental cash flow information
Income taxes	7,253	4,525
Interest	2,852	8,429
Supplemental noncash disclosure:
New commitments to low-income housing partnership investments	$ 3,500	$ 3,477

Business Description

Business Description	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description	Business Description OP Bancorp (the “Company”) is a California corporation whose common stock is quoted on the Nasdaq Global Market under the ticker symbol, “OPBK.” The Company was formed to acquire 100% of the voting equity of Open Bank (the “Bank”) and commenced operation as a bank holding company on June 1, 2016. This transaction was treated as an internal reorganization as all shareholders of the Bank became shareholders of the Company. The Company has no operations other than ownership of the Bank. The Bank is a California state-chartered and FDIC-insured financial institution, which began its operations on June 10, 2005. Headquartered in downtown Los Angeles, California, the Bank operates primarily in the traditional banking business arena that includes accepting deposits and making loans and investments. The Bank’s primary deposit products are demand and time deposits, and the primary lending products are commercial business loans to small to medium sized businesses. The Bank is operating with nine full-service branches, eight of which are located in California, in Downtown Los Angeles, Los Angeles Fashion District, Los Angeles Koreatown, Gardena, Buena Park and Santa Clara, and one full-service branch is located in Carrollton, Texas. The Bank also has four loan production offices in Atlanta, Georgia, Aurora, Colorado, and Lynwood and Seattle, Washington .

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation: The accompanying unaudited Consolidated Financial Statements and notes thereto of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for Form 10-Q and conform to practices within the banking industry and include all of the information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting. The accompanying unaudited Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments), which are necessary for a fair presentation of the financial results for the interim periods presented, including eliminating intercompany transactions and balances. Certain items on the Consolidated Financial Statements and notes for the prior years have been reclassified to conform to the 2021 presentation. The results of operations for the interim periods are not necessarily indicative of the results for the full year. These interim unaudited financial statements should be read in conjunction with the audited Consolidated Financial Statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report on Form 10-K”) . Use of Estimates: To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. The Company could experience a material adverse effect on its business as a result of the impact of the novel coronavirus pandemic (“COVID-19”) and the resulting governmental actions to curtail its spread. It is at least reasonably possible that the estimates based on information which was available at the date of the financial statements will change in the near term due to the COVID-19 pandemic and that the effect of the change would be material to the financial statements, including the allowance for loan losses. The extent to which the COVID-19 pandemic will impact our estimates and assumptions is highly uncertain, and we are unable to make an estimate at this time. Concentration of Risk: Most of the Company’s customers are located within Los Angeles County and the surrounding area. The concentration of loans originated in this area may subject the Company to the risk of adverse impacts associated with economic, regulatory or other developments that could occur in Southern California. The Company has significant concentration in commercial real estate loans. The Company obtains what it believes to be sufficient collateral to secure potential losses. The extent and value of the collateral obtained varies based upon the details underlying each loan agreement. The Company has added the following significant accounting policies as a result of an asset purchase of loan portfolio from Hana Small Business Lending, Inc. (“Hana”) . Asset Purchase: On May 24, 2021, the Company completed the purchase of Hana’s loan portfolio and paid approximately $97.6 million that included loans of $100.0 million at a fair value discount of $8.9 million, servicing assets of $6.1 million and accrued interest receivable of $398 thousand. The following table summarizes the consideration paid for the loan portfolio and the amounts of assets purchased: ($ in thousands) Consideration Cash $ 97,631 Recognized amounts of identifiable assets purchased: Loans (1) $ 100,003 Loan discounts (8,867) Accrued interest receivable 398 Servicing assets 6,097 Total recognized identifiable assets $ 97,631 (1) Consists of $92.2 million of SBA loans, $6.9 million of PPP loans and $919 thousand of real estate loans. Asset Acquisitions : The Company follows the guidance in Accounting Standards Codification (“ASC”) 805, Business Combination , for determining the appropriate accounting treatment for acquisition. Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business , provides an initial fair value screen to determine if substantially all of the fair value of the assets acquired is concentrated in a single asset or group of similar assets. If the initial test is met, the assets acquired would not represent a business combination, but rather an asset acquisition. If the transaction is deemed to be an asset acquisition, the cost accumulation and allocation model is used in which the cost of the acquisition is allocated on a relative fair value basis to the assets acquired. The Company concluded that this transaction did not qualify as a business combination and was accounted for as an asset acquisition in accordance with the “Acquisition of Assets Rather Than a Business” subsections of ASC 805-50 using a cost accumulation model. Purchased Performing Loans : The Company records purchased performing loans at fair value including a discount and recognizes discount accretion using the contractual cash flow method. The fair value discount is accreted as an adjustment to yield over the estimated lives of the loans. The Company evaluated $100.0 million of the loans purchased in accordance with the provisions of ASC 310-20, Nonrefundable Fees and Other Costs and recorded an $8.9 million discount. There was no allowance for loan losses established as of June 30, 2021 for the purchased performing loans. A provision for loan losses is recorded for any further deterioration in these loans subsequent to the acquisition. Recent Accounting Pronouncements: In June 2016, Financial Accounting Standards Board (“ FASB ”) issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held-to-maturity debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses on available-for-sale ( “ AFS ” ) debt securities will be recorded through an allowance for credit losses rather than as a write-down recognized in other comprehensive income (loss) . Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. In July 2019, the FASB proposed the effective date delay to January 2020 for SEC filers, excluding smaller reporting companies (“SRCs”) and emerging growth companies (“EGCs”), and January 2023 for all other entities including SRCs and EGCs, and in October 2019, the FASB voted to approve the proposed delay. The Company expects the adoption date of ASU 2016-13 will be January 2023. ASU 2016-13 will be applied using a modified retrospective approach through a cumulative effect adjustment to retained earnings, except for debt securities that an other-than-temporary impairment had been previously recognized will be applied using the prospective transition approach . The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, including software solutions, data requirements and loss estimation methodologies. The company has engaged a third-party advisor to develop a new expected loss model. While the effects cannot yet be quantified, the Company expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU is a new accounting standard related to contracts or hedging relationships that reference London Interbank Offered Rate (“LIBOR”) or other reference rates that are expected to be discontinued. The new standard provides temporary optional expedients and exceptions regarding existing accounting requirements related to contractual modifications of contracts, hedging relationships, and other transactions that are affected by reference rate reform. In January 2021, the FASB issued ASU 2021-01, as subsequent amendments, which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from referent rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company adopted this guidance on a prospective basis in January 2021 and the guidance did not have a material impact on the Company’s Consolidated Financial Statements. The Company will assess the impact in conjunction with the reference rate transition as it occurs over the next two years. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This amendment simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The effective date will be January 2023. T he Company does not expect the adoption of this guidance will be material to its Consolidated Statement of Income.

Securities

Securities	9 Months Ended
	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Securities	Securities The following table summarizes the amortized cost, the corresponding amounts of gross unrealized gains and losses, and estimated fair value of AFS debt securities as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 27,094 $ 256 $ (136) $ 27,214 Residential collateralized mortgage obligations 75,471 432 (582) 75,321 Total available-for-sale debt securities $ 102,565 $ 688 $ (718) $ 102,535 December 31, 2020 ($ in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale debt securities U.S. Government-sponsored agency securities $ 1,000 $ 5 $ — $ 1,005 U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 19,281 $ 430 $ (7) $ 19,704 Residential collateralized mortgage obligations 70,318 814 (50) 71,082 Total available-for-sale debt securities $ 90,599 $ 1,249 $ (57) $ 91,791 There were no sales of AFS debt securities in the three and nine months ended September 30, 2021 and 2020. The amortized cost and estimated fair value of AFS debt securities at September 30, 2021, by contractual maturity, are shown below. ($ in thousands) Amortized Cost Fair Value Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: After one year through five years $ 732 $ 766 After five years through ten years 3,990 4,133 After ten years 97,843 97,636 Total available-for-sale debt securities $ 102,565 $ 102,535 Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. At September 30, 2021 and December 31, 2020, there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of shareholders’ equity. The following table presents the fair value and the associated gross unrealized losses on AFS debt securities by length of time those individual securities in each category have been in a continuous loss at September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 20,201 $ (136) $ — $ — $ 20,201 $ (136) Residential collateralized mortgage obligations 47,696 (562) 2,626 (20) 50,322 (582) Total available-for-sale debt securities $ 67,897 $ (698) $ 2,626 $ (20) $ 70,523 $ (718) ($ in thousands) December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 3,089 $ (7) $ — $ — $ 3,089 $ (7) Residential collateralized mortgage obligations 13,593 (50) — — 13,593 (50) Total available-for-sale debt securities $ 16,682 $ (57) $ — $ — $ 16,682 $ (57) Management evaluates securities for other-than-temporary impairment (“OTTI”) on a quarterly basis, and more frequently when economic or market conditions warrant such an evaluation. For securities in an unrealized loss position, management considers the extent and duration of the unrealized loss, along with the financial condition and near-term prospects of the issuer. Management also assesses whether it intends to sell, or whether it is more likely than not that it will be required to sell, a security in an unrealized loss position before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the entire difference between amortized cost and fair value is recognized as impairment through earnings. For debt securities that do not meet the aforementioned criteria, the amount of impairment is split into two components, as follows: (i) OTTI related to credit loss, which must be recognized in the income statement, and (ii) OTTI related to other factors, which is recognized in other comprehensive income. The credit loss is defined as the difference between the present value of the cash flows expected to be collected and the amortized cost basis. The unrealized losses were primarily attributable to interest rate movement, not credit quality. These securities (Fannie Mae, Ginnie Mae, and Freddie Mac) are guaranteed or sponsored by agencies of the U.S. government, and the issuers of the securities are of high credit quality. The Company believes that the gross unrealized losses presented in the previous tables are temporary and no credit losses are expected. As a result, the Company expects full collection of the carrying amount of these securities, does not intend to sell the securities in an unrealized loss position, and it was more-likely-than-not the Company will not have to sell these securities prior to recovery of amortized cost. Accordingly, the Company does not consider these securities to be OTTI as of September 30, 2021. As of September 30, 2021 and December 31, 2020, there were no pledged securities to secure public deposits, borrowing and letters of credit from the Federal Home Loan Bank (“FHLB”) and the Board of Governors of the Federal Reserve System (“FRB”), and for other purposes required or permitted by law. The following table presents the other investment securities, which are included in Other investments on the Consolidated Balance Sheet as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Federal Home Loan Bank stock $ 7,005 $ 6,043 Pacific Coast Bankers Bank stock 190 190 Mutual fund - CRA qualified 3,734 3,773 Total other investment securities $ 10,929 $ 10,006

Loans and Allowance for Loan Lo

Loans and Allowance for Loan Losses	9 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Loans and Allowance for Loan Losses	Loans and Allowance for Loan Losses The following table presents the composition of the loan portfolio as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Commercial real estate $ 688,430 $ 651,684 SBA loans—real estate 218,491 136,224 SBA loans—non-real estate (1) 85,134 75,151 Commercial and industrial 123,422 107,307 Home mortgage 115,255 128,212 Consumer 1,089 1,158 Gross loans receivable 1,231,821 1,099,736 Allowance for loan losses (14,134) (15,352) Loans receivable, net (2) $ 1,217,687 $ 1,084,384 (1) As of September 30, 2021 and December 31, 2020, SBA loans - non-real estate balances include SBA Paycheck Protection Program ("PPP") loans of $69.3 million and $64.9 million, respectively. (2) Includes net deferred loan fees or costs, unamortized premiums and unaccreted discounts of $(9.6) million and $(5.9) million as of September 30, 2021 and December 31, 2020, respectively. No loans were outstanding to related parties as of September 30, 2021 or December 31, 2020. The following table summarizes the activity in the allowance for loan losses by portfolio segment for the three and nine months ended September 30, 2021 and 2020: ($ in thousands) Three months ended September 30, 2021 Commercial SBA Loans SBA Commercial Home Consumer Total Beginning balance $ 8,456 $ 1,997 $ 228 $ 2,286 $ 1,704 $ 16 $ 14,687 (Reversal of) provision for loan losses (1) (241) 99 (35) (332) (46) (2) (557) Charge-offs — — — — — — — Recoveries — — 3 — — 1 4 Ending balance $ 8,215 $ 2,096 $ 196 $ 1,954 $ 1,658 $ 15 $ 14,134 Three months ended September 30, 2020 Beginning balance $ 7,145 $ 1,346 $ 253 $ 1,920 $ 2,074 $ 26 $ 12,764 (Reversal of) provision for loan losses (1) 994 412 18 (5) (15) (5) 1,399 Charge-offs — — — — — — — Recoveries — — — — — 1 1 Ending balance $ 8,139 $ 1,758 $ 271 $ 1,915 $ 2,059 $ 22 $ 14,164 (1) Excludes (reversal of) provision for uncollectible accrued interest receivable of $(327) thousand for the three months ended September 30, 2021. There was no provision for uncollectible accrued interest receivable for the three months ended September 30, 2020. Nine Months Ended September 30, 2021 ($ in thousands) Commercial SBA Loans SBA Commercial Home Consumer Total Beginning balance $ 8,505 $ 1,802 $ 278 $ 2,563 $ 2,185 $ 19 $ 15,352 (Reversal of) provision for loan losses (1) (290) 294 (58) (609) (527) (8) (1,198) Charge-offs — — (27) — — — (27) Recoveries — — 3 — — 4 7 Ending balance $ 8,215 $ 2,096 $ 196 $ 1,954 $ 1,658 $ 15 $ 14,134 Nine Months Ended September 30, 2020 Beginning balance $ 6,000 $ 939 $ 121 $ 1,289 $ 1,667 $ 34 $ 10,050 (Reversal of) provision for loan losses (1) 2,139 819 167 626 392 (13) 4,130 Charge-offs — — (45) — — — (45) Recoveries — — 28 — — 1 29 Ending balance $ 8,139 $ 1,758 $ 271 $ 1,915 $ 2,059 $ 22 $ 14,164 (1) Excludes (reversal of) provision for uncollectible accrued interest receivable of ($178) thousand for the nine months ended September 30, 2021. There was no provision for uncollectible accrued interest receivable for the nine months ended September 30, 2020. The following table presents the allowance for loan losses and recorded investment by portfolio segment and impairment methodology as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Loans Individually Evaluated for Impairment Loans Collectively Evaluated for Impairment Total Allowance for loan losses (1) : Commercial real estate $ — $ 8,215 $ 8,215 SBA loans—real estate 109 1,987 2,096 SBA loans—non-real estate — 196 196 Commercial and industrial 320 1,634 1,954 Home mortgage — 1,658 1,658 Consumer — 15 15 Total $ 429 $ 13,705 $ 14,134 Loans (2) : Commercial real estate $ — $ 690,391 $ 690,391 SBA loans—real estate 552 218,950 219,502 SBA loans—non-real estate — 85,644 85,644 Commercial and industrial 320 123,384 123,704 Home mortgage — 115,653 115,653 Consumer — 1,051 1,051 Total $ 872 $ 1,235,073 $ 1,235,945 December 31, 2020 Allowance for loan losses (1) : Commercial real estate $ — $ 8,505 $ 8,505 SBA loans—real estate — 1,802 1,802 SBA loans—non-real estate 87 191 278 Commercial and industrial 330 2,233 2,563 Home mortgage — 2,185 2,185 Consumer — 19 19 Total $ 417 $ 14,935 $ 15,352 Loans (2) : Commercial real estate $ — $ 654,235 $ 654,235 SBA loans—real estate — 136,873 136,873 SBA loans—non-real estate 174 75,477 75,651 Commercial and industrial 330 107,175 107,505 Home mortgage — 128,683 128,683 Consumer — 1,161 1,161 Total $ 504 $ 1,103,604 $ 1,104,108 (1) Excludes allowance for uncollectible accrued interest receivable of $465 thousand and $643 thousand as of September 30, 2021 and December 31, 2020, respectively. (2) Includes accrued interest receivable of $4.1 million and $4.4 million as of September 30, 2021 and December 31, 2020, respectively. The following table presents the recorded investment of individually impaired loans and the specific allowance for loan losses as of September 30, 2021 and December 31, 2020. ($ in thousands) September 30, 2021 December 31, 2020 (1) Unpaid Principal Balance Recorded Recorded Related Recorded Recorded Related SBA loans—real estate $ 786 $ 396 $ 156 $ 109 $ — $ — $ — SBA loans—non-real estate — — — — — 174 87 Commercial and industrial 320 — 320 320 — 330 330 Total $ 1,106 $ 396 $ 476 $ 429 $ — $ 504 $ 417 (1) The difference between the unpaid principal balance (net of partial charge-offs) and the recorded investment in the loans was not considered to be material. The following table presents the average recorded investment in impaired loans and the amount of interest income recognized on impaired loans by portfolio segment for the three and nine months ended September 30, 2021 and 2020. The difference between interest income recognized and cash basis interest recognized was immaterial. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 ($ in thousands) Average Interest Average Interest Average Interest Average Interest SBA loans—real estate $ 540 $ — $ — $ — $ 450 $ — $ — $ — SBA loans—non-real estate — — 122 2 — — 124 5 Commercial and industrial 322 — 330 3 326 — 331 10 Total $ 862 $ — $ 452 $ 5 $ 776 $ — $ 455 $ 15 The following table presents the recorded investment in nonaccrual loans and loans past due 90 or more days and still accruing interest, by portfolio segment, as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Nonaccrual Loans 90 or More Days Past Due & Still Accruing Total SBA loans—real estate $ 544 $ — $ 544 SBA loans—non-real estate 188 — 188 Commercial and industrial 320 — 320 Total $ 1,052 $ — $ 1,052 December 31, 2020 SBA loans—non-real estate $ 56 $ — $ 56 Commercial and industrial 330 — 330 Home mortgage 599 — 599 Total $ 985 $ — $ 985 Nonaccrual loans and loans past due 90 or more days and still accruing interest include both homogeneous loans that are collectively evaluated for impairment and individually classified impaired loans. The following table represents the aging analysis of the recorded investment in past due loans as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) 30-59 Days Past Due 60-89 Days Past Due 90 or More Days Past Due Total Past Due Total Current or Less Than 30 Total Commercial real estate $ — $ — $ — $ — $ 690,391 $ 690,391 SBA—real estate 52 396 148 596 218,906 219,502 SBA—non-real estate 213 20 162 395 85,249 85,644 Commercial and industrial — — — — 123,704 123,704 Home mortgage — 1,056 — $ 1,056 114,597 115,653 Consumer — — — — 1,051 1,051 $ 265 $ 1,472 $ 310 $ 2,047 $ 1,233,898 $ 1,235,945 December 31, 2020 Commercial real estate $ — $ — $ — $ — $ 654,235 $ 654,235 SBA—real estate — — — — 136,873 136,873 SBA—non-real estate — — — — 75,651 75,651 Commercial and industrial — — — — 107,505 107,505 Home mortgage — — 599 599 128,084 128,683 Consumer — — — — 1,161 1,161 $ — $ — $ 599 $ 599 $ 1,103,509 $ 1,104,108 Troubled Debt Restructurings : When, for economic or legal reasons related to a borrower’s financial difficulties, the Company grants a concession for other than an insignificant period of time to a borrower that the Company would not otherwise consider, the related loan is classified as a troubled debt restructuring (“TDR”), the balance of which totaled $320 thousand and $330 thousand as of September 30, 2021 and December 31, 2020, respectively. As of September 30, 2021 and December 31, 2020, the Company has allocated $320 thousand and $330 thousand of specific reserves to the loans classified as TDRs, respectively. The Company has not committed to lend any additional amounts to customers with outstanding loans that are classified as TDRs. Modifications made were primarily extensions of existing payment modifications on loans when the loan was previously identified as TDRs. There were no new loans identified as TDRs during the three and nine months ended September 30, 2021 or 2020. There were no payment defaults during the three and nine months ended September 30, 2021, or 2020, of loans that had been modified as TDRs within the previous twelve months. Loan Payment Deferrals : Through September 30, 2021, the Company has processed loan deferments for borrowers across multiple industries representing 225 loan accounts, with an aggregate loan balance of $250.7 million under the interagency guidance and Section 4013 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). COVID-19 related modifications are generally not classified as TDRs due to the relief under the CARES Act and the interagency guidance, both of which the Company elected to apply. Additionally, the Company’s election to apply the TDR relief provided by the CARES Act and the interagency guidance impacts our regulatory capital ratios as these loan modifications related to COVID-19 are not adjusted to a higher risk-weighting normally required with TDR classification . As of September 30, 2021, 221 loans with an aggregate balance of $244.0 million, including 69 home mortgage loans with an aggregate balance of $30.2 million, have resumed regular payments. The following table represents the loan deferment status change by loan type as of September 30, 2021: Loan Deferment Status Change by Loan Type September 30, 2021 ($ in thousands) Total deferments Payment resumed Remaining deferments Loan Type Number of accounts Balance Number of accounts Balance Number of accounts Balance Loans, excluding home mortgage and consumer loans 156 $ 220,522 152 $ 213,774 4 $ 6,748 Home mortgage loans 69 30,205 69 30,205 — — Total 225 $ 250,727 221 $ 243,979 4 $ 6,748 Paycheck Protection Program loans : A provision in the CARES Act created the PPP, which is administered by the Small Business Administration (“SBA”). The PPP is intended to provide loans to small businesses to pay expenses related to their employees, rent, mortgage interest, and utilities. The loans may be forgiven conditioned upon the client providing applicable documentation evidencing their compliant with the terms of the program, including compliance regarding the use of funds. The Bank is an approved SBA lender and began accepting applications for the program on April 3, 2020. As of September 30, 2021, the Company had loans outstanding with a carrying value of $69.3 million, which were recorded in the SBA – non-real estate. Since the PPP’s inception through September 30, 2021, we have funded $154.5 million, and $88.8 million of principal forgiveness has been provided on qualifying PPP loans. Credit Quality Indicators : The Company monitor credit quality by evaluating various attributes and utilize such information in the evaluation of the appropriateness of the allowance for loan losses. The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. For consumer loans, a credit grade is established at inception, and generally only adjusted based on performance. The Company analyzes loans individually by classifying the loans according to their credit risk. This analysis is performed on a quarterly basis. The Company uses the following definitions for risk ratings: Special Mention—Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the Company’s credit position at some future date. Substandard—Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Doubtful—Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable, and improbable. Loans not meeting the criteria above that are analyzed individually as part of the above-described process are considered to be pass-rated loans. The following table presents the credit risk ratings by portfolio segment as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 Pass Special Mention Substandard Doubtful Total Commercial real estate $ 690,391 $ — $ — $ — $ 690,391 SBA loans—real estate 217,999 — 1,503 — 219,502 SBA loans—non-real estate 85,266 — 347 31 85,644 Commercial and industrial 123,384 — 320 — 123,704 Home mortgage 115,653 — — — 115,653 Consumer 1,051 — — — 1,051 $ 1,233,744 $ — $ 2,170 $ 31 $ 1,235,945 December 31, 2020 Commercial real estate $ 654,235 $ — $ — $ — $ 654,235 SBA loans—real estate 134,815 535 1,523 — 136,873 SBA loans—non-real estate 75,453 — 198 — 75,651 Commercial and industrial 102,500 — 5,005 — 107,505 Home mortgage 128,084 — 599 — 128,683 Consumer 1,161 — — — 1,161 $ 1,096,248 $ 535 $ 7,325 $ — $ 1,104,108

Premises and Equipment

Premises and Equipment	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Premises and Equipment	Premises and Equipment The Company’s premises and equipment consists of the following as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 December 31, 2020 Leasehold improvements $ 7,095 $ 6,878 Furniture and fixtures 3,377 3,307 Equipment and others 2,912 2,593 Total cost 13,384 12,778 Accumulated depreciation (9,185) (8,234) Net book value $ 4,199 $ 4,544 Total depreciation expense included in occupancy and equipment expenses was $332 thousand and $326 thousand for the three months ended September 30, 2021 and 2020, respectively, and $989 thousand and $981 thousand for the nine months ended September 30, 2021 and 2020, respectively.

Servicing Assets

Servicing Assets	9 Months Ended
	Sep. 30, 2021
Servicing Asset [Abstract]
Servicing Assets	Servicing AssetsThe Company recognizes the right to service SBA loans for others as servicing assets when the servicing income the Company receives is more than adequate compensation. Servicing assets are accounted for using the amortization method. Under this method, the Company amortizes the servicing assets over the period of the economic life of the assets arising from estimated net servicing revenue. The Company periodically stratifies its servicing assets into groupings based on risk characteristics and assesses each group for impairment based on fair value. The Servicing assets totaled $12.4 million at September 30, 2021 and $7.4 million at December 31, 2020. Based on the results of the impairment test, there were no valuation allowance for impairment as of both September 30, 2021 and December 31, 2020. The following table presents an analysis of the changes in activity for loan servicing assets during the three and nine months ended September 30, 2021 and 2020 is as follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in thousands) 2021 2020 2021 2020 Beginning balance $ 12,903 $ 6,972 $ 7,360 $ 7,024 Additions from loans sold with servicing retained 533 585 1,380 1,354 Additions from purchase of servicing rights — — 6,097 — Amortized to expense (1,047) (335) (2,448) (1,156) Ending balance $ 12,389 $ 7,222 $ 12,389 $ 7,222 The fair value of the servicing assets was $15.1 million at September 30, 2021, which was determined using discount rates ranging from 3.8% to 10.0% and prepayment speeds ranging from 14.3% to 14.7%, depending on the stratification of the specific assets.

Deposits

Deposits	9 Months Ended
	Sep. 30, 2021
Deposits [Abstract]
Deposits	Deposits Time deposits that exceed the FDIC insurance limit of $250,000 at September 30, 2021 and December 31, 2020 were $209.1 million and $200.2 million, respectively. The scheduled maturities of time deposits as of September 30, 2021 were as follows: ($ in thousands) September 30, 2021 Remainder of 2021 $ 127,429 2022 299,157 2023 3,132 2024 1,387 2025 768 Thereafter 206 Total $ 432,079

Borrowing Arrangements

Borrowing Arrangements	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Borrowing Arrangements	Borrowing Arrangements As of September 30, 2021, the Company did not have any borrowings from the FHLB of San Francisco, compared with $5.0 million as of December 31, 2020, which had a zero interest rate under the Recovery Advance Program to support pandemic relief. The Company had a letter of credit with the FHLB in the amount of $67.0 million to secure public deposits as of both September 30, 2021 and December 31, 2020. The Company had available borrowings from the following institutions as of September 30, 2021: ($ in thousands) September 30, 2021 Federal Home Loan Bank—San Francisco $ 333,351 Federal Reserve Bank—San Francisco 138,607 Pacific Coast Bankers Bank 50,000 Zions Bank 25,000 First Horizon Bank 25,000 Total $ 571,958 The Company has pledged approximately $906.3 million and $909.2 million of loans as collateral for these lines of credit as of September 30, 2021 and December 31, 2020, respectively.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s income tax expense was $3.2 million and $1.5 million for the three months ended September 30, 2021 and 2020, respectively, and $8.1 million and $3.6 million for the nine months ended September 30, 2021 and 2020, respectively. The effective income tax rate was 28.2% and 28.9% for the three months ended September 30, 2021 and 2020, respectively, and 29.0% and 27.9% for the nine months ended September 30, 2021 and 2020, respectively. The Company is subject to U.S. Federal income tax as well as various state taxing jurisdictions. The Company is no longer subject to examination by Federal taxing authorities for tax years prior to 2017 and for state taxing authorities for tax years prior to 2016.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Off-Balance-Sheet Credit Risk : In the normal course of business, the Company enters into commitments to extend credit such as loan commitments and standby letters of credits (“SBLC”s). These commitments expose the Company to varying degrees of credit and market risk and are subject to the same credit and market risk limitation reviews as those instruments recorded on the Consolidated Balance Sheet. Loan commitments represent arrangements to lend funds or provide liquidity subject to specified contractual conditions. Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. These commitments generally have fixed expiration dates or contain termination clauses in the event the customer’s credit quality deteriorates. Since many of the commitments are expected to expire without being drawn upon, the commitment amounts do not necessarily represent future funding requirements. The Company applies the same credit underwriting criteria to extend loans and commitments to customers. Each customer’s credit worthiness is evaluated on a case-by-case basis. Collateral may be obtained based on management’s assessment of a customer’s credit. Collateral may include securities, accounts receivable, inventory, property, plant and equipment, and income producing commercial or other properties. The following table shows the distribution of undisbursed credit-related commitments as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Loan commitments $ 147,889 $ 75,740 Standby letters of credits 5,514 9,212 Commercial letters of credit 757 1,552 Total undisbursed credit related commitments $ 154,160 $ 86,504 The majority of these off-balance sheet commitments have a variable interest rate. Management does not anticipate any material losses as a result of these transactions. Investments in low-income housing partnership : The Company invests in qualified affordable housing partnerships. The following table shows the Company’s investments in low-income housing partnerships, net, and related unfunded commitments as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Investments in low-income housing partnerships $ 8,028 $ 4,932 Unfunded commitments to fund investments for low-income housing partnerships $ 5,020 $ 2,154 These balances are reflected in other assets and other liabilities on the Consolidated Balance Sheets. The Company expects to finish fulfilling these commitments during the year ending 2035. Under the proportional amortization method, the Company amortizes the initial cost of the investment in proportion to the tax credit and other benefits received and recognizes the amortization in income tax expense on the Consolidated Statements of Income and Comprehensive Income. The Company recognized amortization expense of $151 thousand and $107 thousand for the three months ended September 30, 2021 and 2020, respectively, and $405 thousand and $268 thousand for the nine months ended September 30, 2021 and 2020, respectively. Additionally, the Company recognized tax credits and other benefits received from the investments in low-income housing partnerships of $190 thousand and $83 thousand for the three months ended September 30, 2021 and 2020, and $506 thousand and $230 thousand for the nine months ended September 30, 2021 and 2020, respectively.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation The Company has three stock-based compensation plans currently in effect as of September 30, 2021, as described further below. Total compensation cost charged against income for these plans was $167 thousand and $403 thousand for the three and nine months ended September 30, 2021, and total compensation cost charged against income for these plans was $249 thousand and $965 thousand for the three and nine months ended September 30, 2020, respectively. 2005 Plan : In 2005, the Board of Directors and shareholders of the Bank approved a stock option plan for the benefit of directors and employees of the Bank (the “2005 Plan”). The 2005 Plan was assumed by the Company in 2016 at the time of the bank holding company reorganization. Under the 2005 Plan, the Bank was authorized to grant options to purchase up to 770,000 shares of the Company’s common stock. The exercise prices of the options may not be less than 100% of the fair value of the Company’s common stock at the date of grant. The options, when granted, vest either immediately or ratably over five years from the date of the grant and expire after ten years if not exercised. The 2005 Plan expired in 2015 and no future grants can be made under the 2005 Plan. A summary of the transactions under the 2005 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except per share data) Number of Weighted Aggregate Outstanding, as of January 1, 2021 100,000 $ 5.77 Options granted — — Options exercised (40,000) 1.60 Options forfeited — — Options expired — — Outstanding, as of September 30, 2021 60,000 6.28 $ 241 Fully vested and expected to vest 60,000 6.28 241 Vested 60,000 $ 6.28 $ 241 Information related to the 2005 Plan for the periods indicated is as follows: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Intrinsic value of options exercised $ — $ — $ 174 $ 370 Cash received from option exercises $ — $ — $ 64 $ 63 Tax benefit realized from option exercised $ — $ — $ 20 $ 17 The weighted average remaining contractual term of stock options outstanding under the 2005 Plan as of September 30, 2021 was 1.98 years. All stock options that are outstanding under the 2005 Plan were fully vested and exercisable as of September 30, 2021. 2010 Plan : In 2010, the Board of Directors of the Bank approved an equity incentive plan for granting stock options and restricted stock awards to key employees, officers, and non-employee directors of the Bank (the “2010 Plan”). In 2013, the 2010 Plan was amended and approved by the shareholders to increase the number of shares authorized to be issued from 1,350,000 shares of common stock to 2,500,000 shares of common stock. The 2010 Plan was assumed by the Company in 2016 at the time of the bank holding company reorganization. The exercise prices of stock options granted under the plan may not be less than 100% of the fair value of the Company’s stock at the date of grant. The options, when granted, vest ratably over five years from the date of the grant and expire after ten years if not exercised. The 2010 Plan expired in August 2020 and no future grants can be made under the 2010 Plan. Restricted stock awards issued under the 2010 Plan may or may not be subject to vesting provisions. Owners of the restricted stock awards shall have all rights of a shareholder including the right to vote the shares and to all dividends (cash or stock). Compensation expense related to restricted stock awards will be recognized over the vesting period of the awards based on the fair value of the Company’s common stock at the issue date. A summary of stock options outstanding under the 2010 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except per share data) Number of Weighted Aggregate Outstanding, as of January 1, 2021 220,000 $ 7.75 Options granted — — Options exercised (10,000) 2.53 Options forfeited — — Options expired — — Outstanding, as of September 30, 2021 210,000 8.00 $ 483 Fully vested and expected to vest 210,000 8.00 483 Vested 210,000 $ 8.00 $ 483 Information related to stock options exercised under the 2010 Plan for the periods indicated is as follows: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Intrinsic value of options exercised $ — $ — $ 86 $ 608 Cash received from option exercises $ — $ — $ 25 $ 242 Tax benefit realized from option exercised $ — $ — $ — $ 157 The weighted average remaining contractual term of stock options outstanding under the 2010 Plan as of September 30, 2021 was 2.50 years. All stock options that are outstanding under the 2010 Plan were fully vested and exercisable as of September 30, 2021. A summary of the changes in the Company’s non-vested restricted stock awards under the 2010 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except share data) Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested, as of January 1, 2021 154,500 $ 11.66 Awards granted — — Awards vested (128,500) 12.34 Awards forfeited (5,000) 9.69 Non-vested, as of September 30, 2021 21,000 $ 7.95 $ 216 Information related to non-vested restricted stock awards under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in thousands) 2021 2020 2021 2020 Tax benefit (provision) realized from awards vested $ — $ 24 $ (85) $ 21 The Company had approximately $69 thousand of unrecognized compensation cost related to unvested restricted stock awards under the 2010 Plan as of September 30, 2021. The Company expects to recognize these costs over a weighted average period of 2.43 years. 2021 Plan : In 2021, the Board of Directors of the Company approved a new equity incentive plan for granting stock options and restricted stock awards to key employees, officers, and non-employee directors of the Company and the Bank (the “2021 Plan”). The 2021 Plan was approved by the Company’s shareholders at the 2021 Annual Meeting. The number of shares authorized to be issued under the 2021 Plan was 1,500,000 shares of the Company’s common stock. The exercise prices of stock options granted under the plan may not be less than 100% of the fair value of the Company’s stock at the date of grant. There were no stock options granted under the 2021 Plan during the nine months ended September 30, 2021. Restricted stock awards issued under the 2021 Plan may or may not be subject to vesting provisions. Owners of the restricted stock awards shall have all rights of a shareholder including the right to vote the shares and to all dividends (cash or stock). Compensation expense related to restricted stock awards will be recognized over the vesting period of the awards based on the fair value of the Company’s common stock at the issue date. A summary of the changes in the Company’s non-vested restricted stock awards under the 2021 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except share data) Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested, as of January 1, 2021 — $ — Awards granted 176,793 9.90 Awards vested (152) 9.90 Awards forfeited — — Non-vested, as of September 30, 2021 176,641 $ 9.90 $ 1,819 No tax benefits or expenses were realized from restricted stock awards under the 2021 Plan for the nine months ended September 30, 2021.

Employee Benefit Plan

Employee Benefit Plan	9 Months Ended
	Sep. 30, 2021
Retirement Benefits [Abstract]
Employee Benefit Plan	Employee Benefit PlanThe Company sponsors a defined contribution plan, 401(k) profit sharing plan (the “401(k) Plan”), designed to provide retirement benefits financed by participant contributions, as well as contributions from the Company. Employees are eligible to participate in the 401(k) Plan as of the first day of the first calendar month after the date they have completed three months of service with the Company and have attained the age of 18. Each employee is allowed to contribute to the 401(k) Plan up to the maximum percentage allowable, not to exceed the limits of applicable IRS Code Sections. Each year, the Company may, in its discretion, make matching contributions to the 401(k) Plan. Total employer contributions to the 401(k) Plan amounted to $188 thousand and $170 thousand for the three months ended September 30, 2021 and 2020, respectively, $557 thousand and $526 thousand for the nine months ended September 30, 2021 and 2020, respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability on the measurement date and is determined using an exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Assets and liabilities recorded at fair value on a recurring basis, such as AFS securities and equity investments. Additionally, from time to time, the Company records fair value adjustments on a nonrecurring basis. These nonrecurring adjustments typically involve application of lower of cost or fair value accounting and write-downs of individual assets. The Company classify its assets and liabilities recorded at fair value as one of the following three categories and a financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement: Level 1—Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2—Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3—Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. Assets and Liabilities Measured at Fair Value on a Recurring Basis Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy. Securities AFS : The fair values of investment securities AFS are determined by matrix pricing, which is a mathematical technique used to value debt securities without relying exclusively on quoted prices for the specific securities, but rather by relying on the securities’ relationship to other benchmark quoted securities (Level 2). Management obtains the fair values of investment securities on a monthly basis from a third-party pricing service. Other Investment : The Company has equity investment with readily determinable fair value. The fair value for the equity investment with readily determinable fair value is obtained from unadjusted quoted prices in active markets on the date of measurement and classified as Level 1. Assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 are summarized below: Fair Value Measure on a Recurring Basis ($ in thousands) September 30, 2021 Total Quoted Significant Other Significant U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 27,214 $ — $ 27,214 $ — Residential collateralized mortgage obligations $ 75,321 $ — $ 75,321 $ — Other investment securities: Mutual fund - CRA qualified $ 3,734 $ 3,734 $ — $ — December 31, 2020 U.S. Government sponsored agency securities $ 1,005 $ — $ 1,005 $ — U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 19,704 $ — $ 19,704 $ — Residential collateralized mortgage obligations $ 71,082 $ — $ 71,082 $ — Other investment securities: Mutual fund - CRA qualified $ 3,773 $ 3,773 $ — $ — There were no transfers between Level 1 and Level 2 for the three and nine months ended September 30, 2021 or 2020. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis The Company may be required, from time to time, to measure certain assets at fair value on a nonrecurring basis in accordance with GAAP. These adjustments to fair value usually result from application of lower of cost or fair value and write-downs of individual assets. Impaired Loans : The fair value of impaired loans with specific allocations of the allowance for loan losses is generally based on recent real estate appraisals. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are usually significant and typically result in a Level 3 classification of the inputs for determining fair value. Non-real estate collateral may be valued using an appraisal, net book value per the borrower’s financial statements, or aging reports, adjusted or discounted based on management’s judgment, changes in market conditions from the time of the valuation, and management’s expertise and knowledge of the client and client’s business, resulting in a Level 3 fair value classification. Impaired loans are evaluated on a quarterly basis for additional impairment and adjusted accordingly. Appraisals for collateral-dependent impaired loans are performed by certified general appraisers (for commercial properties) or certified residential appraisers (for residential properties) whose qualifications and licenses have been reviewed and verified by the Company. Once received, a member of the credit department reviews the assumptions and approaches utilized in the appraisal as well as the overall resulting fair value in comparison with independent data sources such as recent market data or industry-wide statistics. The following table presents the fair value hierarchy and fair value of assets that were still held and had fair value adjustments measured on a nonrecurring basis as of September 30, 2021 and December 31, 2020: ($ in thousands) Fair Value Measure on a Nonrecurring Basis September 30, 2021 Total Quoted Significant Other Significant Impaired loans $ 443 $ — $ — $ 443 December 31, 2020 Impaired loans $ 87 $ — $ — $ 87 The following table presents the increase (decrease) in value of certain assets held at the end of the respective reporting periods presented for which a nonrecurring fair value adjustment was recognized during the period presented: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Impaired loans $ (106) $ — $ (99) $ (56) The following table presents information about significant unobservable inputs utilized in the Company’s nonrecurring Level 3 fair value measurements as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Fair Value Valuation Unobservable Range of Weighted- Average of Inputs (1) Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—real estate $ 47 Market approach Market data comparison (13.0)% to 18.0% (0.1)% SBA loans—real estate $ 396 Income approach - income capitalization Capitalization rate 12.0% 12.0% December 31, 2020 Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—non-real estate $ 62 Income approach - discounted cash flows Discount rate 5.3% 5.3% SBA loans—non-real estate $ 25 Market approach Market data comparison (3.5)% to 7.1% 2.9% (1) Weighted-average of inputs is based on the relative fair value of the respective assets as of September 30, 2021 and December 31, 2020. (2) Applying fair value adjustments on the impaired loan through the full specific reserve allowance of the loan carrying value resulted in a zero fair value balance as of September 30, 2021 and December 31, 2020. Financial Instruments : The carrying amounts and estimated fair values of financial instruments that are not carried at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 are as follows. These financial assets and liabilities are measured at amortized cost basis on the Company’s Consolidated Balance Sheet: ($ in thousands) September 30, 2021 Carrying Amount Level 1 Level 2 Level 3 Estimated Fair Value Financial Assets: Cash and cash equivalents $ 188,145 $ 188,145 $ — $ — $ 188,145 Loans held for sale $ 94,466 $ — $ 104,218 $ — $ 104,218 Loans receivable, net $ 1,217,687 $ — $ — $ 1,217,597 $ 1,217,597 Accrued interest receivable, net $ 3,931 $ 5 $ 267 $ 3,659 $ 3,931 Other investments: FHLB and PCBB stock $ 7,195 N/A N/A N/A N/A Time deposits placed $ 96 $ — $ 96 $ — $ 96 Servicing assets $ 12,389 $ — $ — $ 15,138 $ 15,138 Financial Liabilities: Deposit $ 1,496,406 $ — $ 1,497,270 $ — $ 1,497,270 Accrued interest payable $ 575 $ — $ 575 $ — $ 575 ($ in thousands) December 31, 2020 Carrying Amount Level 1 Level 2 Level 3 Estimated Fair Value Financial Assets: Cash and cash equivalents $ 106,310 $ 106,310 $ — $ — $ 106,310 Loans held for sale $ 26,659 $ — $ 26,659 $ — $ 26,659 Loans receivable, net $ 1,084,384 $ — $ — $ 1,109,217 $ 1,109,217 Accrued interest receivable, net $ 3,985 $ 7 $ 249 $ 3,729 $ 3,985 Other investments: FHLB and PCBB stock $ 6,233 N/A N/A N/A N/A Time deposits placed $ 95 $ — $ 95 $ — $ 95 Servicing assets $ 7,360 $ — $ — $ 9,106 $ 9,106 Financial Liabilities: Deposit $ 1,200,090 $ — $ 1,200,789 $ — $ 1,200,789 FHLB Advances $ 5,000 $ — $ 5,000 $ — $ 5,000 Accrued interest payable $ 1,021 $ — $ 1,021 $ — $ 1,021

Regulatory Capital Matters

Regulatory Capital Matters	9 Months Ended
	Sep. 30, 2021
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Regulatory Capital Matters	Regulatory Capital Matters Under the Basel III rules, the Bank must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. As of September 30, 2021, the capital conservation buffers for the Company is 2.50%. Management believes that as of September 30, 2021 and December 31, 2020, the Bank met all capital adequacy requirements to which they are subject to. Based on recent changes to the Federal Reserve’s definition of a “Small Bank Holding Company” that increased the threshold to $3 billion in assets, the Company is not currently subject to separate minimum capital measurements. At such time as the Company reaches the $3 billion asset level, it will again be subject to capital measurements independent of the Bank. For comparison purposes, the Company’s ratios are included in following discussion as well. Unrealized gain or loss on securities available-for-sale is not included in computing regulatory capital. The following table presents the regulatory capital amounts and ratios for the Company and the Bank as of dates indicated: ($ in thousands) September 30, 2021 Actual (1) Required for Minimum Amount Ratio Amount Ratio Amount Ratio Total capital (to risk-weighted assets) Consolidated $ 172,873 13.81 % N/A N/A N/A N/A Bank 170,171 13.60 % 100,135 8.00 % 125,169 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 158,126 12.63 % N/A N/A N/A N/A Bank 155,424 12.42 % 75,101 6.00 % 100,135 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 158,126 12.63 % N/A N/A N/A N/A Bank 155,424 12.42 % 56,326 4.50 % 81,360 6.50 % Tier 1 leverage (to average assets) Consolidated 158,126 9.75 % N/A N/A N/A N/A Bank 155,424 9.58 % 64,875 4.00 % 81,094 5.00 % (1) The capital requirements are only applicable to the Bank, and the Company's ratios are included for comparison purpose. ($ in thousands) December 31, 2020 Actual (1) Required for Minimum Amount Ratio Amount Ratio Amount Ratio Total capital (to risk-weighted assets) Consolidated $ 155,287 14.81 % N/A N/A N/A N/A Bank 152,232 14.52 % 83,859 8.00 % 104,824 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 142,147 13.56 % N/A N/A N/A N/A Bank 139,092 13.27 % 62,894 6.00 % 83,859 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 142,147 13.56 % N/A N/A N/A N/A Bank 139,092 13.27 % 47,171 4.50 % 68,136 6.50 % Tier 1 leverage (to average assets) Consolidated 142,147 10.55 % N/A N/A N/A N/A Bank 139,092 10.32 % 53,915 4.00 % 67,393 5.00 % (1) The capital requirements are only applicable to the Bank, and the Company's ratios are included for comparison purpose.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share The two-class method is used in the calculation of basic and diluted earnings per share. Under the two-class method, earnings available to common shares are allocated between common shares and participating securities. The Company’s restricted stock awards are considered participating securities as the unvested awards have non-forfeitable rights to dividends, paid or unpaid, on unvested awards. The factors used in the earnings per share computation are as follows: ($ in thousands, except share and per share data) Three Months Ended 2021 2020 Basic Net income $ 8,250 $ 3,595 Undistributed earnings allocated to participating securities (109) (44) Net income allocated to common shares $ 8,141 $ 3,551 Weighted average common shares outstanding 15,133,407 15,148,833 Basic earnings per common share $ 0.54 $ 0.23 Diluted Net income allocated to common shares $ 8,141 $ 3,551 Weighted average common shares outstanding for basic earnings per common share 15,133,407 15,148,833 Add: Dilutive effects of assumed exercises of stock options 67,206 33,900 Average shares and dilutive potential common shares 15,200,613 15,182,733 Diluted earnings per common share $ 0.54 $ 0.23 No stock options for shares of common stock were antidilutive for the three months ended September 30, 2021. Stock options for 262 thousand shares of common stock were antidilutive for the three months ended September 30, 2020 . ($ in thousands, except share and per share data) Nine Months Ended 2021 2020 Basic Net income $ 19,706 $ 9,310 Undistributed earnings allocated to participating securities (216) (154) Net income allocated to common shares $ 19,490 $ 9,156 Weighted average common shares outstanding 15,071,327 15,235,617 Basic earnings per common share $ 1.29 $ 0.60 Diluted Net income allocated to common shares $ 19,490 $ 9,156 Weighted average common shares outstanding for basic earnings per common share 15,071,327 15,235,617 Add: Dilutive effects of assumed exercises of stock options 62,246 48,573 Average shares and dilutive potential common shares 15,133,573 15,284,190 Diluted earnings per common share $ 1.29 $ 0.60 No stock options for shares of common stock were antidilutive for the nine months ended September 30, 2021. Stock options for 212 thousand shares of common stock were antidilutive for the nine months ended September 30, 2020.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The accompanying unaudited Consolidated Financial Statements and notes thereto of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for Form 10-Q and conform to practices within the banking industry and include all of the information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting. The accompanying unaudited Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments), which are necessary for a fair presentation of the financial results for the interim periods presented, including eliminating intercompany transactions and balances. Certain items on the Consolidated Financial Statements and notes for the prior years have been reclassified to conform to the 2021 presentation. The results of operations for the interim periods are not necessarily indicative of the results for the full year. These interim unaudited financial statements should be read in conjunction with the audited Consolidated Financial Statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Annual Report on Form 10-K”) .
Use of Estimates	Use of Estimates: To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. The Company could experience a material adverse effect on its business as a result of the impact of the novel coronavirus pandemic (“COVID-19”) and the resulting governmental actions to curtail its spread. It is at least reasonably possible that the estimates based on information which was available at the date of the financial statements will change in the near term due to the COVID-19 pandemic and that the effect of the change would be material to the financial statements, including the allowance for loan losses. The extent to which the COVID-19 pandemic will impact our estimates and assumptions is highly uncertain, and we are unable to make an estimate at this time.
Concentration of Risk	Concentration of Risk: Most of the Company’s customers are located within Los Angeles County and the surrounding area. The concentration of loans originated in this area may subject the Company to the risk of adverse impacts associated with economic, regulatory or other developments that could occur in Southern California. The Company has significant concentration in commercial real estate loans. The Company obtains what it believes to be sufficient collateral to secure potential losses. The extent and value of the collateral obtained varies based upon the details underlying each loan agreement. The Company has added the following significant accounting policies as a result of an asset purchase of loan portfolio from Hana Small Business Lending, Inc. (“Hana”)
Asset Acquisitions	Asset Acquisitions : The Company follows the guidance in Accounting Standards Codification (“ASC”) 805, Business Combination , for determining the appropriate accounting treatment for acquisition. Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business , provides an initial fair value screen to determine if substantially all of the fair value of the assets acquired is concentrated in a single asset or group of similar assets. If the initial test is met, the assets acquired would not represent a business combination, but rather an asset acquisition. If the transaction is deemed to be an asset acquisition, the cost accumulation and allocation model is used in which the cost of the acquisition is allocated on a relative fair value basis to the assets acquired. The Company concluded that this transaction did not qualify as a business combination and was accounted for as an asset acquisition in accordance with the “Acquisition of Assets Rather Than a Business” subsections of ASC 805-50 using a cost accumulation model.
Purchased Performing Loans	Purchased Performing Loans : The Company records purchased performing loans at fair value including a discount and recognizes discount accretion using the contractual cash flow method. The fair value discount is accreted as an adjustment to yield over the estimated lives of the loans. The Company evaluated $100.0 million of the loans purchased in accordance with the provisions of ASC 310-20, Nonrefundable Fees and Other Costs and recorded an $8.9 million discount. There was no allowance for loan losses established as of June 30, 2021 for the purchased performing loans. A provision for loan losses is recorded for any further deterioration in these loans subsequent to the acquisition.
Recent Accounting Pronouncements	Recent Accounting Pronouncements: In June 2016, Financial Accounting Standards Board (“ FASB ”) issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held-to-maturity debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses on available-for-sale ( “ AFS ” ) debt securities will be recorded through an allowance for credit losses rather than as a write-down recognized in other comprehensive income (loss) . Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. In July 2019, the FASB proposed the effective date delay to January 2020 for SEC filers, excluding smaller reporting companies (“SRCs”) and emerging growth companies (“EGCs”), and January 2023 for all other entities including SRCs and EGCs, and in October 2019, the FASB voted to approve the proposed delay. The Company expects the adoption date of ASU 2016-13 will be January 2023. ASU 2016-13 will be applied using a modified retrospective approach through a cumulative effect adjustment to retained earnings, except for debt securities that an other-than-temporary impairment had been previously recognized will be applied using the prospective transition approach . The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, including software solutions, data requirements and loss estimation methodologies. The company has engaged a third-party advisor to develop a new expected loss model. While the effects cannot yet be quantified, the Company expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU is a new accounting standard related to contracts or hedging relationships that reference London Interbank Offered Rate (“LIBOR”) or other reference rates that are expected to be discontinued. The new standard provides temporary optional expedients and exceptions regarding existing accounting requirements related to contractual modifications of contracts, hedging relationships, and other transactions that are affected by reference rate reform. In January 2021, the FASB issued ASU 2021-01, as subsequent amendments, which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from referent rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company adopted this guidance on a prospective basis in January 2021 and the guidance did not have a material impact on the Company’s Consolidated Financial Statements. The Company will assess the impact in conjunction with the reference rate transition as it occurs over the next two years. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This amendment simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The effective date will be January 2023. T he Company does not expect the adoption of this guidance will be material to its Consolidated Statement of Income.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Consideration Paid for Loan portfolio and Amounts of Assets Purchased	The following table summarizes the consideration paid for the loan portfolio and the amounts of assets purchased: ($ in thousands) Consideration Cash $ 97,631 Recognized amounts of identifiable assets purchased: Loans (1) $ 100,003 Loan discounts (8,867) Accrued interest receivable 398 Servicing assets 6,097 Total recognized identifiable assets $ 97,631 (1) Consists of $92.2 million of SBA loans, $6.9 million of PPP loans and $919 thousand of real estate loans.

Securities (Tables)

Securities (Tables)	9 Months Ended
	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost, Corresponding Amounts of Gross Unrealized Gains and Losses and Estimated Fair Value of AFS Debt Securities	The following table summarizes the amortized cost, the corresponding amounts of gross unrealized gains and losses, and estimated fair value of AFS debt securities as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 27,094 $ 256 $ (136) $ 27,214 Residential collateralized mortgage obligations 75,471 432 (582) 75,321 Total available-for-sale debt securities $ 102,565 $ 688 $ (718) $ 102,535 December 31, 2020 ($ in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale debt securities U.S. Government-sponsored agency securities $ 1,000 $ 5 $ — $ 1,005 U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 19,281 $ 430 $ (7) $ 19,704 Residential collateralized mortgage obligations 70,318 814 (50) 71,082 Total available-for-sale debt securities $ 90,599 $ 1,249 $ (57) $ 91,791
Schedule of Amortized Cost and Estimated Fair Value of AFS Debt Securities by Contractual Maturity	The amortized cost and estimated fair value of AFS debt securities at September 30, 2021, by contractual maturity, are shown below. ($ in thousands) Amortized Cost Fair Value Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: After one year through five years $ 732 $ 766 After five years through ten years 3,990 4,133 After ten years 97,843 97,636 Total available-for-sale debt securities $ 102,565 $ 102,535
Schedule of Fair Value and Associated Gross Unrealized Losses on AFS Debt Securities by Length of Time in Continuous Loss	The following table presents the fair value and the associated gross unrealized losses on AFS debt securities by length of time those individual securities in each category have been in a continuous loss at September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 20,201 $ (136) $ — $ — $ 20,201 $ (136) Residential collateralized mortgage obligations 47,696 (562) 2,626 (20) 50,322 (582) Total available-for-sale debt securities $ 67,897 $ (698) $ 2,626 $ (20) $ 70,523 $ (718) ($ in thousands) December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale debt securities U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 3,089 $ (7) $ — $ — $ 3,089 $ (7) Residential collateralized mortgage obligations 13,593 (50) — — 13,593 (50) Total available-for-sale debt securities $ 16,682 $ (57) $ — $ — $ 16,682 $ (57)
Schedule of Other Investments Securities	The following table presents the other investment securities, which are included in Other investments on the Consolidated Balance Sheet as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Federal Home Loan Bank stock $ 7,005 $ 6,043 Pacific Coast Bankers Bank stock 190 190 Mutual fund - CRA qualified 3,734 3,773 Total other investment securities $ 10,929 $ 10,006

Loans and Allowance for Loan _2

Loans and Allowance for Loan Losses (Tables)	9 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Composition of Loan Portfolio	The following table presents the composition of the loan portfolio as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Commercial real estate $ 688,430 $ 651,684 SBA loans—real estate 218,491 136,224 SBA loans—non-real estate (1) 85,134 75,151 Commercial and industrial 123,422 107,307 Home mortgage 115,255 128,212 Consumer 1,089 1,158 Gross loans receivable 1,231,821 1,099,736 Allowance for loan losses (14,134) (15,352) Loans receivable, net (2) $ 1,217,687 $ 1,084,384 (1) As of September 30, 2021 and December 31, 2020, SBA loans - non-real estate balances include SBA Paycheck Protection Program ("PPP") loans of $69.3 million and $64.9 million, respectively. (2) Includes net deferred loan fees or costs, unamortized premiums and unaccreted discounts of $(9.6) million and $(5.9) million as of September 30, 2021 and December 31, 2020, respectively.
Schedule of Activity in Allowance for Loan Losses by Portfolio Segment	The following table summarizes the activity in the allowance for loan losses by portfolio segment for the three and nine months ended September 30, 2021 and 2020: ($ in thousands) Three months ended September 30, 2021 Commercial SBA Loans SBA Commercial Home Consumer Total Beginning balance $ 8,456 $ 1,997 $ 228 $ 2,286 $ 1,704 $ 16 $ 14,687 (Reversal of) provision for loan losses (1) (241) 99 (35) (332) (46) (2) (557) Charge-offs — — — — — — — Recoveries — — 3 — — 1 4 Ending balance $ 8,215 $ 2,096 $ 196 $ 1,954 $ 1,658 $ 15 $ 14,134 Three months ended September 30, 2020 Beginning balance $ 7,145 $ 1,346 $ 253 $ 1,920 $ 2,074 $ 26 $ 12,764 (Reversal of) provision for loan losses (1) 994 412 18 (5) (15) (5) 1,399 Charge-offs — — — — — — — Recoveries — — — — — 1 1 Ending balance $ 8,139 $ 1,758 $ 271 $ 1,915 $ 2,059 $ 22 $ 14,164 (1) Excludes (reversal of) provision for uncollectible accrued interest receivable of $(327) thousand for the three months ended September 30, 2021. There was no provision for uncollectible accrued interest receivable for the three months ended September 30, 2020. Nine Months Ended September 30, 2021 ($ in thousands) Commercial SBA Loans SBA Commercial Home Consumer Total Beginning balance $ 8,505 $ 1,802 $ 278 $ 2,563 $ 2,185 $ 19 $ 15,352 (Reversal of) provision for loan losses (1) (290) 294 (58) (609) (527) (8) (1,198) Charge-offs — — (27) — — — (27) Recoveries — — 3 — — 4 7 Ending balance $ 8,215 $ 2,096 $ 196 $ 1,954 $ 1,658 $ 15 $ 14,134 Nine Months Ended September 30, 2020 Beginning balance $ 6,000 $ 939 $ 121 $ 1,289 $ 1,667 $ 34 $ 10,050 (Reversal of) provision for loan losses (1) 2,139 819 167 626 392 (13) 4,130 Charge-offs — — (45) — — — (45) Recoveries — — 28 — — 1 29 Ending balance $ 8,139 $ 1,758 $ 271 $ 1,915 $ 2,059 $ 22 $ 14,164 (1) Excludes (reversal of) provision for uncollectible accrued interest receivable of ($178) thousand for the nine months ended September 30, 2021. There was no provision for uncollectible accrued interest receivable for the nine months ended September 30, 2020. The following table presents the allowance for loan losses and recorded investment by portfolio segment and impairment methodology as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Loans Individually Evaluated for Impairment Loans Collectively Evaluated for Impairment Total Allowance for loan losses (1) : Commercial real estate $ — $ 8,215 $ 8,215 SBA loans—real estate 109 1,987 2,096 SBA loans—non-real estate — 196 196 Commercial and industrial 320 1,634 1,954 Home mortgage — 1,658 1,658 Consumer — 15 15 Total $ 429 $ 13,705 $ 14,134 Loans (2) : Commercial real estate $ — $ 690,391 $ 690,391 SBA loans—real estate 552 218,950 219,502 SBA loans—non-real estate — 85,644 85,644 Commercial and industrial 320 123,384 123,704 Home mortgage — 115,653 115,653 Consumer — 1,051 1,051 Total $ 872 $ 1,235,073 $ 1,235,945 December 31, 2020 Allowance for loan losses (1) : Commercial real estate $ — $ 8,505 $ 8,505 SBA loans—real estate — 1,802 1,802 SBA loans—non-real estate 87 191 278 Commercial and industrial 330 2,233 2,563 Home mortgage — 2,185 2,185 Consumer — 19 19 Total $ 417 $ 14,935 $ 15,352 Loans (2) : Commercial real estate $ — $ 654,235 $ 654,235 SBA loans—real estate — 136,873 136,873 SBA loans—non-real estate 174 75,477 75,651 Commercial and industrial 330 107,175 107,505 Home mortgage — 128,683 128,683 Consumer — 1,161 1,161 Total $ 504 $ 1,103,604 $ 1,104,108 (1) Excludes allowance for uncollectible accrued interest receivable of $465 thousand and $643 thousand as of September 30, 2021 and December 31, 2020, respectively. (2) Includes accrued interest receivable of $4.1 million and $4.4 million as of September 30, 2021 and December 31, 2020, respectively.
Schedule of Impaired Loans and Specific Allowance	The following table presents the recorded investment of individually impaired loans and the specific allowance for loan losses as of September 30, 2021 and December 31, 2020. ($ in thousands) September 30, 2021 December 31, 2020 (1) Unpaid Principal Balance Recorded Recorded Related Recorded Recorded Related SBA loans—real estate $ 786 $ 396 $ 156 $ 109 $ — $ — $ — SBA loans—non-real estate — — — — — 174 87 Commercial and industrial 320 — 320 320 — 330 330 Total $ 1,106 $ 396 $ 476 $ 429 $ — $ 504 $ 417 (1) The difference between the unpaid principal balance (net of partial charge-offs) and the recorded investment in the loans was not considered to be material. The following table presents the average recorded investment in impaired loans and the amount of interest income recognized on impaired loans by portfolio segment for the three and nine months ended September 30, 2021 and 2020. The difference between interest income recognized and cash basis interest recognized was immaterial. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 ($ in thousands) Average Interest Average Interest Average Interest Average Interest SBA loans—real estate $ 540 $ — $ — $ — $ 450 $ — $ — $ — SBA loans—non-real estate — — 122 2 — — 124 5 Commercial and industrial 322 — 330 3 326 — 331 10 Total $ 862 $ — $ 452 $ 5 $ 776 $ — $ 455 $ 15
Schedule of Recorded Investment in Nonaccrual Loans and Loans Past Due 90 or More Days and Still Accruing Interest by Portfolio Segment	The following table presents the recorded investment in nonaccrual loans and loans past due 90 or more days and still accruing interest, by portfolio segment, as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Nonaccrual Loans 90 or More Days Past Due & Still Accruing Total SBA loans—real estate $ 544 $ — $ 544 SBA loans—non-real estate 188 — 188 Commercial and industrial 320 — 320 Total $ 1,052 $ — $ 1,052 December 31, 2020 SBA loans—non-real estate $ 56 $ — $ 56 Commercial and industrial 330 — 330 Home mortgage 599 — 599 Total $ 985 $ — $ 985
Schedule of Aging Analysis of Recorded Investment in Past Due Loans	The following table represents the aging analysis of the recorded investment in past due loans as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) 30-59 Days Past Due 60-89 Days Past Due 90 or More Days Past Due Total Past Due Total Current or Less Than 30 Total Commercial real estate $ — $ — $ — $ — $ 690,391 $ 690,391 SBA—real estate 52 396 148 596 218,906 219,502 SBA—non-real estate 213 20 162 395 85,249 85,644 Commercial and industrial — — — — 123,704 123,704 Home mortgage — 1,056 — $ 1,056 114,597 115,653 Consumer — — — — 1,051 1,051 $ 265 $ 1,472 $ 310 $ 2,047 $ 1,233,898 $ 1,235,945 December 31, 2020 Commercial real estate $ — $ — $ — $ — $ 654,235 $ 654,235 SBA—real estate — — — — 136,873 136,873 SBA—non-real estate — — — — 75,651 75,651 Commercial and industrial — — — — 107,505 107,505 Home mortgage — — 599 599 128,084 128,683 Consumer — — — — 1,161 1,161 $ — $ — $ 599 $ 599 $ 1,103,509 $ 1,104,108
Schedule of Loan Deferment Status Change by Loan Type	The following table represents the loan deferment status change by loan type as of September 30, 2021: Loan Deferment Status Change by Loan Type September 30, 2021 ($ in thousands) Total deferments Payment resumed Remaining deferments Loan Type Number of accounts Balance Number of accounts Balance Number of accounts Balance Loans, excluding home mortgage and consumer loans 156 $ 220,522 152 $ 213,774 4 $ 6,748 Home mortgage loans 69 30,205 69 30,205 — — Total 225 $ 250,727 221 $ 243,979 4 $ 6,748
Schedule of Credit Risk Ratings by Portfolio Segment	The following table presents the credit risk ratings by portfolio segment as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 Pass Special Mention Substandard Doubtful Total Commercial real estate $ 690,391 $ — $ — $ — $ 690,391 SBA loans—real estate 217,999 — 1,503 — 219,502 SBA loans—non-real estate 85,266 — 347 31 85,644 Commercial and industrial 123,384 — 320 — 123,704 Home mortgage 115,653 — — — 115,653 Consumer 1,051 — — — 1,051 $ 1,233,744 $ — $ 2,170 $ 31 $ 1,235,945 December 31, 2020 Commercial real estate $ 654,235 $ — $ — $ — $ 654,235 SBA loans—real estate 134,815 535 1,523 — 136,873 SBA loans—non-real estate 75,453 — 198 — 75,651 Commercial and industrial 102,500 — 5,005 — 107,505 Home mortgage 128,084 — 599 — 128,683 Consumer 1,161 — — — 1,161 $ 1,096,248 $ 535 $ 7,325 $ — $ 1,104,108

Premises and Equipment (Tables)

Premises and Equipment (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of Premises and Equipment	The Company’s premises and equipment consists of the following as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, 2021 December 31, 2020 Leasehold improvements $ 7,095 $ 6,878 Furniture and fixtures 3,377 3,307 Equipment and others 2,912 2,593 Total cost 13,384 12,778 Accumulated depreciation (9,185) (8,234) Net book value $ 4,199 $ 4,544

Servicing Assets (Tables)

Servicing Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Servicing Asset [Abstract]
Schedule of Changes in Activity for Loan Servicing Assets	The following table presents an analysis of the changes in activity for loan servicing assets during the three and nine months ended September 30, 2021 and 2020 is as follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in thousands) 2021 2020 2021 2020 Beginning balance $ 12,903 $ 6,972 $ 7,360 $ 7,024 Additions from loans sold with servicing retained 533 585 1,380 1,354 Additions from purchase of servicing rights — — 6,097 — Amortized to expense (1,047) (335) (2,448) (1,156) Ending balance $ 12,389 $ 7,222 $ 12,389 $ 7,222

Deposits (Tables)

Deposits (Tables)	9 Months Ended
	Sep. 30, 2021
Deposits [Abstract]
Schedule of Maturities of Time Deposits	The scheduled maturities of time deposits as of September 30, 2021 were as follows: ($ in thousands) September 30, 2021 Remainder of 2021 $ 127,429 2022 299,157 2023 3,132 2024 1,387 2025 768 Thereafter 206 Total $ 432,079

Borrowing Arrangements (Tables)

Borrowing Arrangements (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Summary of Borrowings Available to the Company from Institutions	The Company had available borrowings from the following institutions as of September 30, 2021: ($ in thousands) September 30, 2021 Federal Home Loan Bank—San Francisco $ 333,351 Federal Reserve Bank—San Francisco 138,607 Pacific Coast Bankers Bank 50,000 Zions Bank 25,000 First Horizon Bank 25,000 Total $ 571,958

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of Distribution of Undisbursed Credit-related Commitments	The following table shows the distribution of undisbursed credit-related commitments as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Loan commitments $ 147,889 $ 75,740 Standby letters of credits 5,514 9,212 Commercial letters of credit 757 1,552 Total undisbursed credit related commitments $ 154,160 $ 86,504
Schedule of Investments in Low Income Housing Partnerships, Net and Related Unfunded Commitments	The following table shows the Company’s investments in low-income housing partnerships, net, and related unfunded commitments as of September 30, 2021 and December 31, 2020: ($ in thousands) September 30, December 31, Investments in low-income housing partnerships $ 8,028 $ 4,932 Unfunded commitments to fund investments for low-income housing partnerships $ 5,020 $ 2,154

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of Stock-based Compensation Stock Options Activity	A summary of the transactions under the 2005 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except per share data) Number of Weighted Aggregate Outstanding, as of January 1, 2021 100,000 $ 5.77 Options granted — — Options exercised (40,000) 1.60 Options forfeited — — Options expired — — Outstanding, as of September 30, 2021 60,000 6.28 $ 241 Fully vested and expected to vest 60,000 6.28 241 Vested 60,000 $ 6.28 $ 241 A summary of stock options outstanding under the 2010 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except per share data) Number of Weighted Aggregate Outstanding, as of January 1, 2021 220,000 $ 7.75 Options granted — — Options exercised (10,000) 2.53 Options forfeited — — Options expired — — Outstanding, as of September 30, 2021 210,000 8.00 $ 483 Fully vested and expected to vest 210,000 8.00 483 Vested 210,000 $ 8.00 $ 483
Summary of Information Related to Stock Option Plan	Information related to the 2005 Plan for the periods indicated is as follows: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Intrinsic value of options exercised $ — $ — $ 174 $ 370 Cash received from option exercises $ — $ — $ 64 $ 63 Tax benefit realized from option exercised $ — $ — $ 20 $ 17 Information related to stock options exercised under the 2010 Plan for the periods indicated is as follows: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Intrinsic value of options exercised $ — $ — $ 86 $ 608 Cash received from option exercises $ — $ — $ 25 $ 242 Tax benefit realized from option exercised $ — $ — $ — $ 157
Summary of Changes in Non-vested Restricted Stock Awards	A summary of the changes in the Company’s non-vested restricted stock awards under the 2010 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except share data) Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested, as of January 1, 2021 154,500 $ 11.66 Awards granted — — Awards vested (128,500) 12.34 Awards forfeited (5,000) 9.69 Non-vested, as of September 30, 2021 21,000 $ 7.95 $ 216 A summary of the changes in the Company’s non-vested restricted stock awards under the 2021 Plan for the nine months ended September 30, 2021 is as follows: ($ in thousands, except share data) Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested, as of January 1, 2021 — $ — Awards granted 176,793 9.90 Awards vested (152) 9.90 Awards forfeited — — Non-vested, as of September 30, 2021 176,641 $ 9.90 $ 1,819
Summary of Information Related to Non-vested Restricted Stock Awards	Information related to non-vested restricted stock awards under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in thousands) 2021 2020 2021 2020 Tax benefit (provision) realized from awards vested $ — $ 24 $ (85) $ 21

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 are summarized below: Fair Value Measure on a Recurring Basis ($ in thousands) September 30, 2021 Total Quoted Significant Other Significant U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 27,214 $ — $ 27,214 $ — Residential collateralized mortgage obligations $ 75,321 $ — $ 75,321 $ — Other investment securities: Mutual fund - CRA qualified $ 3,734 $ 3,734 $ — $ — December 31, 2020 U.S. Government sponsored agency securities $ 1,005 $ — $ 1,005 $ — U.S. Government agencies or sponsored agency securities: Residential mortgage-backed securities $ 19,704 $ — $ 19,704 $ — Residential collateralized mortgage obligations $ 71,082 $ — $ 71,082 $ — Other investment securities: Mutual fund - CRA qualified $ 3,773 $ 3,773 $ — $ —
Summary of Fair Value Hierarchy and Fair Value of Assets that Were Still Held and Had Fair Value Adjustments Measured On a Nonrecurring Basis	The following table presents the fair value hierarchy and fair value of assets that were still held and had fair value adjustments measured on a nonrecurring basis as of September 30, 2021 and December 31, 2020: ($ in thousands) Fair Value Measure on a Nonrecurring Basis September 30, 2021 Total Quoted Significant Other Significant Impaired loans $ 443 $ — $ — $ 443 December 31, 2020 Impaired loans $ 87 $ — $ — $ 87
Summary of Increase (Decrease) In Value of Certain Assets Held at End of Respective Reporting Periods Presented for Which a Nonrecurring Fair Value Adjustment	The following table presents the increase (decrease) in value of certain assets held at the end of the respective reporting periods presented for which a nonrecurring fair value adjustment was recognized during the period presented: ($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Impaired loans $ (106) $ — $ (99) $ (56)
Summary of Information about Significant Unobservable Inputs Utilized in Company's Nonrecurring Level 3 Fair Value Measurements	The following table presents information about significant unobservable inputs utilized in the Company’s nonrecurring Level 3 fair value measurements as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Fair Value Valuation Unobservable Range of Weighted- Average of Inputs (1) Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—real estate $ 47 Market approach Market data comparison (13.0)% to 18.0% (0.1)% SBA loans—real estate $ 396 Income approach - income capitalization Capitalization rate 12.0% 12.0% December 31, 2020 Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—non-real estate $ 62 Income approach - discounted cash flows Discount rate 5.3% 5.3% SBA loans—non-real estate $ 25 Market approach Market data comparison (3.5)% to 7.1% 2.9% (1) Weighted-average of inputs is based on the relative fair value of the respective assets as of September 30, 2021 and December 31, 2020. (2) Applying fair value adjustments on the impaired loan through the full specific reserve allowance of the loan carrying value resulted in a zero fair value balance as of September 30, 2021 and December 31, 2020.
Summary of Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value	Financial Instruments : The carrying amounts and estimated fair values of financial instruments that are not carried at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 are as follows. These financial assets and liabilities are measured at amortized cost basis on the Company’s Consolidated Balance Sheet: ($ in thousands) September 30, 2021 Carrying Amount Level 1 Level 2 Level 3 Estimated Fair Value Financial Assets: Cash and cash equivalents $ 188,145 $ 188,145 $ — $ — $ 188,145 Loans held for sale $ 94,466 $ — $ 104,218 $ — $ 104,218 Loans receivable, net $ 1,217,687 $ — $ — $ 1,217,597 $ 1,217,597 Accrued interest receivable, net $ 3,931 $ 5 $ 267 $ 3,659 $ 3,931 Other investments: FHLB and PCBB stock $ 7,195 N/A N/A N/A N/A Time deposits placed $ 96 $ — $ 96 $ — $ 96 Servicing assets $ 12,389 $ — $ — $ 15,138 $ 15,138 Financial Liabilities: Deposit $ 1,496,406 $ — $ 1,497,270 $ — $ 1,497,270 Accrued interest payable $ 575 $ — $ 575 $ — $ 575 ($ in thousands) December 31, 2020 Carrying Amount Level 1 Level 2 Level 3 Estimated Fair Value Financial Assets: Cash and cash equivalents $ 106,310 $ 106,310 $ — $ — $ 106,310 Loans held for sale $ 26,659 $ — $ 26,659 $ — $ 26,659 Loans receivable, net $ 1,084,384 $ — $ — $ 1,109,217 $ 1,109,217 Accrued interest receivable, net $ 3,985 $ 7 $ 249 $ 3,729 $ 3,985 Other investments: FHLB and PCBB stock $ 6,233 N/A N/A N/A N/A Time deposits placed $ 95 $ — $ 95 $ — $ 95 Servicing assets $ 7,360 $ — $ — $ 9,106 $ 9,106 Financial Liabilities: Deposit $ 1,200,090 $ — $ 1,200,789 $ — $ 1,200,789 FHLB Advances $ 5,000 $ — $ 5,000 $ — $ 5,000 Accrued interest payable $ 1,021 $ — $ 1,021 $ — $ 1,021

Regulatory Capital Matters (Tab

Regulatory Capital Matters (Tables)	9 Months Ended
	Sep. 30, 2021
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Summary of Actual and Required Capital Amounts and Ratios	The following table presents the regulatory capital amounts and ratios for the Company and the Bank as of dates indicated: ($ in thousands) September 30, 2021 Actual (1) Required for Minimum Amount Ratio Amount Ratio Amount Ratio Total capital (to risk-weighted assets) Consolidated $ 172,873 13.81 % N/A N/A N/A N/A Bank 170,171 13.60 % 100,135 8.00 % 125,169 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 158,126 12.63 % N/A N/A N/A N/A Bank 155,424 12.42 % 75,101 6.00 % 100,135 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 158,126 12.63 % N/A N/A N/A N/A Bank 155,424 12.42 % 56,326 4.50 % 81,360 6.50 % Tier 1 leverage (to average assets) Consolidated 158,126 9.75 % N/A N/A N/A N/A Bank 155,424 9.58 % 64,875 4.00 % 81,094 5.00 % (1) The capital requirements are only applicable to the Bank, and the Company's ratios are included for comparison purpose. ($ in thousands) December 31, 2020 Actual (1) Required for Minimum Amount Ratio Amount Ratio Amount Ratio Total capital (to risk-weighted assets) Consolidated $ 155,287 14.81 % N/A N/A N/A N/A Bank 152,232 14.52 % 83,859 8.00 % 104,824 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 142,147 13.56 % N/A N/A N/A N/A Bank 139,092 13.27 % 62,894 6.00 % 83,859 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 142,147 13.56 % N/A N/A N/A N/A Bank 139,092 13.27 % 47,171 4.50 % 68,136 6.50 % Tier 1 leverage (to average assets) Consolidated 142,147 10.55 % N/A N/A N/A N/A Bank 139,092 10.32 % 53,915 4.00 % 67,393 5.00 % (1) The capital requirements are only applicable to the Bank, and the Company's ratios are included for comparison purpose.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The factors used in the earnings per share computation are as follows: ($ in thousands, except share and per share data) Three Months Ended 2021 2020 Basic Net income $ 8,250 $ 3,595 Undistributed earnings allocated to participating securities (109) (44) Net income allocated to common shares $ 8,141 $ 3,551 Weighted average common shares outstanding 15,133,407 15,148,833 Basic earnings per common share $ 0.54 $ 0.23 Diluted Net income allocated to common shares $ 8,141 $ 3,551 Weighted average common shares outstanding for basic earnings per common share 15,133,407 15,148,833 Add: Dilutive effects of assumed exercises of stock options 67,206 33,900 Average shares and dilutive potential common shares 15,200,613 15,182,733 Diluted earnings per common share $ 0.54 $ 0.23 No stock options for shares of common stock were antidilutive for the three months ended September 30, 2021. Stock options for 262 thousand shares of common stock were antidilutive for the three months ended September 30, 2020 . ($ in thousands, except share and per share data) Nine Months Ended 2021 2020 Basic Net income $ 19,706 $ 9,310 Undistributed earnings allocated to participating securities (216) (154) Net income allocated to common shares $ 19,490 $ 9,156 Weighted average common shares outstanding 15,071,327 15,235,617 Basic earnings per common share $ 1.29 $ 0.60 Diluted Net income allocated to common shares $ 19,490 $ 9,156 Weighted average common shares outstanding for basic earnings per common share 15,071,327 15,235,617 Add: Dilutive effects of assumed exercises of stock options 62,246 48,573 Average shares and dilutive potential common shares 15,133,573 15,284,190 Diluted earnings per common share $ 1.29 $ 0.60

Business Description - Addition

Business Description - Additional Information (Details)	Sep. 30, 2021branchoffice	Jun. 01, 2016
Business Description [Line Items]
Number of full service branches | branch	9
Number of loan production offices | office	4
Open Bank
Business Description [Line Items]
Percentage of voting equity interests acquired		100.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	May 24, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Loans		$ 1,217,687		$ 1,084,384
Servicing assets		12,389		7,360
Accrued interest receivable		3,931		3,985
Loans receivable, allowance		$ 14,134	$ 14,687	$ 15,352	$ 14,164	$ 12,764	$ 10,050
Hana Small Business Lending Inc
Summary Of Significant Accounting Policies [Line Items]
Payments to purchase loan portfolio	$ 97,631
Loans	100,003
Fair value discount of loans	8,867
Servicing assets	6,097
Accrued interest receivable	398
Purchased Performing Loans | Hana Small Business Lending Inc
Summary Of Significant Accounting Policies [Line Items]
Loans	100,000
Fair value discount of loans	$ 8,900
Loans receivable, allowance			$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Consideration Paid for Loan Portfolio and Amounts of Assets Purchased (Details) - USD ($) $ in Thousands	May 24, 2021	Sep. 30, 2021	Dec. 31, 2020
Loans And Leases Receivable Disclosure [Line Items]
Loans		$ 1,217,687	$ 1,084,384
Accrued interest receivable		3,931	3,985
Servicing assets		12,389	7,360
Total assets		$ 1,679,911	$ 1,366,826
Hana Small Business Lending Inc
Loans And Leases Receivable Disclosure [Line Items]
Cash	$ 97,631
Loans	100,003
Loan discounts	(8,867)
Accrued interest receivable	398
Servicing assets	6,097
Total assets	97,631
SBA Loans | Hana Small Business Lending Inc
Loans And Leases Receivable Disclosure [Line Items]
Loans	92,200
SBA Loans | PPP loans | Hana Small Business Lending Inc
Loans And Leases Receivable Disclosure [Line Items]
Loans	6,900
Real Estate Loans | Hana Small Business Lending Inc
Loans And Leases Receivable Disclosure [Line Items]
Loans	$ 919

Securities - Schedule of Amorti

Securities - Schedule of Amortized Cost, Corresponding Amounts of Gross Unrealized Gains and Losses and Estimated Fair Value of AFS Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Securities [Line Items]
Available for sale, Amortized Cost	$ 102,565	$ 90,599
Gross Unrealized Gains	688	1,249
Gross Unrealized Losses	(718)	(57)
Available-for-sale debt securities, at fair value	102,535	91,791
U.S. Government-sponsored agency securities
Securities [Line Items]
Available for sale, Amortized Cost		1,000
Gross Unrealized Gains		5
Gross Unrealized Losses		0
Available-for-sale debt securities, at fair value		1,005
Residential mortgage-backed securities
Securities [Line Items]
Available for sale, Amortized Cost	27,094	19,281
Gross Unrealized Gains	256	430
Gross Unrealized Losses	(136)	(7)
Available-for-sale debt securities, at fair value	27,214	19,704
Residential collateralized mortgage obligations
Securities [Line Items]
Available for sale, Amortized Cost	75,471	70,318
Gross Unrealized Gains	432	814
Gross Unrealized Losses	(582)	(50)
Available-for-sale debt securities, at fair value	$ 75,321	$ 71,082

Securities - Additional Informa

Securities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Securities [Line Items]
Proceeds from sale of AFS securities	$ 0	$ 0	$ 0	$ 0
Equity investment in mutual fund with readily determinable fair value	3,700,000		3,700,000		$ 3,800,000
Other Income
Securities [Line Items]
Unrealized holding gains (losses) of mutual fund	(14,000)	$ 0	(73,000)	$ 89,000
Pledged Securities
Securities [Line Items]
Number of pledged securities	$ 0		$ 0		$ 0

Securities - Schedule of Amor_2

Securities - Schedule of Amortized Cost and Estimated Fair Value of Securities AFS Debt Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Amortized Cost
Available for sale, Amortized Cost	$ 102,565	$ 90,599
Fair Value
Available for sale, Fair Value	102,535	$ 91,791
U.S. Government Agencies or Sponsored Agency Securities
Amortized Cost
After one year through five years	732
After five years through ten years	3,990
After ten years	97,843
Available for sale, Amortized Cost	102,565
Fair Value
After one year through five years	766
After five years through ten years	4,133
After ten years	97,636
Available for sale, Fair Value	$ 102,535

Securities -Schedule of Fair Va

Securities -Schedule of Fair Value and Associated Gross Unrealized Losses on AFS Debt Securities by Length of Time in Continuous Loss (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Securities [Line Items]
Fair Value, Less Than 12 Months	$ 67,897	$ 16,682
Gross Unrealized Losses, Less Than 12 Months	(698)	(57)
Fair Value, 12 Months or Longer	2,626	0
Gross Unrealized Losses, 12 Months or Longer	(20)	0
Total Fair Value	70,523	16,682
Total Gross Unrealized Losses	(718)	(57)
Residential mortgage-backed securities
Securities [Line Items]
Fair Value, Less Than 12 Months	20,201	3,089
Gross Unrealized Losses, Less Than 12 Months	(136)	(7)
Fair Value, 12 Months or Longer	0	0
Gross Unrealized Losses, 12 Months or Longer	0	0
Total Fair Value	20,201	3,089
Total Gross Unrealized Losses	(136)	(7)
Residential collateralized mortgage obligations
Securities [Line Items]
Fair Value, Less Than 12 Months	47,696	13,593
Gross Unrealized Losses, Less Than 12 Months	(562)	(50)
Fair Value, 12 Months or Longer	2,626	0
Gross Unrealized Losses, 12 Months or Longer	(20)	0
Total Fair Value	50,322	13,593
Total Gross Unrealized Losses	$ (582)	$ (50)

Securities - Schedule of Other

Securities - Schedule of Other Investments Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Securities [Line Items]
Equity investment in mutual fund with readily determinable fair value	$ 3,700	$ 3,800
Other Investments
Securities [Line Items]
Federal Home Loan Bank stock	7,005	6,043
Pacific Coast Bankers Bank stock	190	190
Equity investment in mutual fund with readily determinable fair value	3,734	3,773
Total other investment securities	$ 10,929	$ 10,006

Loans and Allowance for Loan _3

Loans and Allowance for Loan Losses - Composition of Loan Portfolio (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	$ 1,231,821		$ 1,099,736
Allowance for loan losses	(14,134)	$ (14,687)	(15,352)	$ (14,164)	$ (12,764)	$ (10,050)
Loans receivable, net	1,217,687		1,084,384
Deferred loan fees, unamortized premiums and unaccreted discounts	9,600		5,900
Real Estate | Commercial Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	688,430		651,684
Real Estate | SBA Loans—Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	218,491		136,224
SBA Loans Non- Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	85,134		75,151
Allowance for loan losses	(196)	(228)	(278)	(271)	(253)	(121)
SBA Loans Non- Real Estate | PPP loans
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	69,300		64,900
Commercial and Industrial
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	123,422		107,307
Allowance for loan losses	(1,954)	(2,286)	(2,563)	(1,915)	(1,920)	(1,289)
Home Mortgage
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	115,255		128,212
Allowance for loan losses	(1,658)	(1,704)	(2,185)	(2,059)	(2,074)	(1,667)
Consumer
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	1,089		1,158
Allowance for loan losses	(15)	(16)	(19)	(22)	(26)	(34)
Commercial Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Allowance for loan losses	(8,215)	(8,456)	(8,505)	(8,139)	(7,145)	(6,000)
SBA Loans Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Allowance for loan losses	$ (2,096)	$ (1,997)	$ (1,802)	$ (1,758)	$ (1,346)	$ (939)

Loans and Allowance for Loan _4

Loans and Allowance for Loan Losses - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)loan	Sep. 30, 2020USD ($)loan	Sep. 30, 2021USD ($)loan	Sep. 30, 2020USD ($)loan	Dec. 31, 2020USD ($)
Loans And Leases Receivable Disclosure [Line Items]
Loans, related parties	$ 0		$ 0		$ 0
Recorded investment in troubled debt restructurings	320,000		320,000		330,000
Specific reserves to loans classified as TDRs	$ 320,000		$ 320,000		330,000
Loans identified as TDRs | loan	0	0	0	0
Financing receivable, modifications, subsequent default, recorded investment	$ 0	$ 0	$ 0	$ 0
Gross loans receivable	1,235,945,000		1,235,945,000		1,104,108,000
SBA PPP Loan
Loans And Leases Receivable Disclosure [Line Items]
Total loans funded	154,500,000		154,500,000
Loans forgiven	(88,800,000)		(88,800,000)
Home Mortgage
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	115,653,000		115,653,000		128,683,000
SBA Loans Non- Real Estate
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	85,644,000		85,644,000		$ 75,651,000
SBA Loans Non- Real Estate | SBA PPP Loan
Loans And Leases Receivable Disclosure [Line Items]
Gross loans receivable	$ 69,300,000		$ 69,300,000

Loans and Allowance for Loan _5

Loans and Allowance for Loan Losses - Schedule of Activity in Allowance for Loan Losses by Portfolio Segment (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Analysis of allowance for loan losses
Beginning balance	$ 14,687,000	$ 12,764,000	$ 15,352,000	$ 10,050,000
(Reversal of) provision for loan losses	(557,000)	1,399,000	(1,198,000)	4,130,000
Charge-offs	0	0	(27,000)	(45,000)
Recoveries	4,000	1,000	7,000	29,000
Ending balance	14,134,000	14,164,000	14,134,000	14,164,000
(Reversal of) provision for loan losses	(884,000)	1,399,000	(1,376,000)	4,130,000
Uncollectible Accrued Interest Receivable
Analysis of allowance for loan losses
(Reversal of) provision for loan losses	(327,000)	0	(178,000)	0
Commercial Real Estate
Analysis of allowance for loan losses
Beginning balance	8,456,000	7,145,000	8,505,000	6,000,000
(Reversal of) provision for loan losses	(241,000)	994,000	(290,000)	2,139,000
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Ending balance	8,215,000	8,139,000	8,215,000	8,139,000
SBA Loans Real Estate
Analysis of allowance for loan losses
Beginning balance	1,997,000	1,346,000	1,802,000	939,000
(Reversal of) provision for loan losses	99,000	412,000	294,000	819,000
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Ending balance	2,096,000	1,758,000	2,096,000	1,758,000
SBA Loans Non- Real Estate
Analysis of allowance for loan losses
Beginning balance	228,000	253,000	278,000	121,000
(Reversal of) provision for loan losses	(35,000)	18,000	(58,000)	167,000
Charge-offs	0	0	(27,000)	(45,000)
Recoveries	3,000	0	3,000	28,000
Ending balance	196,000	271,000	196,000	271,000
Commercial and Industrial
Analysis of allowance for loan losses
Beginning balance	2,286,000	1,920,000	2,563,000	1,289,000
(Reversal of) provision for loan losses	(332,000)	(5,000)	(609,000)	626,000
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Ending balance	1,954,000	1,915,000	1,954,000	1,915,000
Home Mortgage
Analysis of allowance for loan losses
Beginning balance	1,704,000	2,074,000	2,185,000	1,667,000
(Reversal of) provision for loan losses	(46,000)	(15,000)	(527,000)	392,000
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Ending balance	1,658,000	2,059,000	1,658,000	2,059,000
Consumer
Analysis of allowance for loan losses
Beginning balance	16,000	26,000	19,000	34,000
(Reversal of) provision for loan losses	(2,000)	(5,000)	(8,000)	(13,000)
Charge-offs	0	0	0	0
Recoveries	1,000	1,000	4,000	1,000
Ending balance	$ 15,000	$ 22,000	$ 15,000	$ 22,000

Loans and Allowance for Loan _6

Loans and Allowance for Loan Losses - Schedule of Allowance for Loan Losses and Recorded Investment by Portfolio Segment and Impairment Methodology (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	$ 429		$ 417
Allowance for Loan Collectively Evaluated for Impairment	13,705		14,935
Total	14,134	$ 14,687	15,352	$ 14,164	$ 12,764	$ 10,050
Loans Individually Evaluated for Impairment	872		504
Loans Collectively Evaluated for Impairment	1,235,073		1,103,604
Total	1,235,945		1,104,108
Allowance for uncollectible accrued interest receivable	465		643
Accrued interest receivable	4,100		4,400
Commercial Real Estate
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	0		0
Allowance for Loan Collectively Evaluated for Impairment	8,215		8,505
Total	8,215	8,456	8,505	8,139	7,145	6,000
Loans Individually Evaluated for Impairment	0		0
Loans Collectively Evaluated for Impairment	690,391		654,235
Total	690,391		654,235
SBA Loans Real Estate
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	109		0
Allowance for Loan Collectively Evaluated for Impairment	1,987		1,802
Total	2,096	1,997	1,802	1,758	1,346	939
Loans Individually Evaluated for Impairment	552		0
Loans Collectively Evaluated for Impairment	218,950		136,873
Total	219,502		136,873
SBA Loans Non- Real Estate
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	0		87
Allowance for Loan Collectively Evaluated for Impairment	196		191
Total	196	228	278	271	253	121
Loans Individually Evaluated for Impairment	0		174
Loans Collectively Evaluated for Impairment	85,644		75,477
Total	85,644		75,651
Commercial and Industrial
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	320		330
Allowance for Loan Collectively Evaluated for Impairment	1,634		2,233
Total	1,954	2,286	2,563	1,915	1,920	1,289
Loans Individually Evaluated for Impairment	320		330
Loans Collectively Evaluated for Impairment	123,384		107,175
Total	123,704		107,505
Home Mortgage
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	0		0
Allowance for Loan Collectively Evaluated for Impairment	1,658		2,185
Total	1,658	1,704	2,185	2,059	2,074	1,667
Loans Individually Evaluated for Impairment	0		0
Loans Collectively Evaluated for Impairment	115,653		128,683
Total	115,653		128,683
Consumer
Financing Receivable Allowance For Credit Losses [Line Items]
Allowance for Loans Individually Evaluated for Impairment	0		0
Allowance for Loan Collectively Evaluated for Impairment	15		19
Total	15	$ 16	19	$ 22	$ 26	$ 34
Loans Individually Evaluated for Impairment	0		0
Loans Collectively Evaluated for Impairment	1,051		1,161
Total	$ 1,051		$ 1,161

Loans and Allowance for Loan _7

Loans and Allowance for Loan Losses - Schedule of Recorded Investment of Individually Impaired Loans and Specific Allowance for Loan Losses (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable Allowance For Credit Losses [Line Items]
Unpaid Principal Balance	$ 1,106
Recorded Investment With No Allowance	396	$ 0
Recorded Investment With Allowance	476	504
Related Allowance	429	417
SBA Loans Real Estate
Financing Receivable Allowance For Credit Losses [Line Items]
Unpaid Principal Balance	786
Recorded Investment With No Allowance	396	0
Recorded Investment With Allowance	156	0
Related Allowance	109	0
SBA Loans Non- Real Estate
Financing Receivable Allowance For Credit Losses [Line Items]
Unpaid Principal Balance	0
Recorded Investment With No Allowance	0	0
Recorded Investment With Allowance	0	174
Related Allowance	0	87
Commercial and Industrial
Financing Receivable Allowance For Credit Losses [Line Items]
Unpaid Principal Balance	320
Recorded Investment With No Allowance	0	0
Recorded Investment With Allowance	320	330
Related Allowance	$ 320	$ 330

Loans and Allowance for Loan _8

Loans and Allowance for Loan Losses - Schedule of Average Recorded Investment In Impaired Loans and Amount of Interest Income Recognized on Impaired Loans by Portfolio Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Financing Receivable Impaired [Line Items]
Average Recorded Investment	$ 862	$ 452	$ 776	$ 455
Interest Income Recognized	0	5	0	15
SBA Loans Real Estate
Financing Receivable Impaired [Line Items]
Average Recorded Investment	540	0	450	0
Interest Income Recognized	0	0	0	0
SBA Loans Non- Real Estate
Financing Receivable Impaired [Line Items]
Average Recorded Investment	0	122	0	124
Interest Income Recognized	0	2	0	5
Commercial and Industrial
Financing Receivable Impaired [Line Items]
Average Recorded Investment	322	330	326	331
Interest Income Recognized	$ 0	$ 3	$ 0	$ 10

Loans and Allowance for Loan _9

Loans and Allowance for Loan Losses - Schedule of Recorded Investment in Nonaccrual Loans and Loans Past Due 90 or More Days and Still Accruing Interest by Portfolio Segment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable Recorded Investment Past Due [Line Items]
Nonaccrual	$ 1,052	$ 985
Loans 90 or More Days Past Due & Still Accruing	0	0
Total	1,052	985
SBA Loans Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Nonaccrual	544
Loans 90 or More Days Past Due & Still Accruing	0
Total	544
SBA Loans Non- Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Nonaccrual	188	56
Loans 90 or More Days Past Due & Still Accruing	0	0
Total	188	56
Commercial and Industrial
Financing Receivable Recorded Investment Past Due [Line Items]
Nonaccrual	320	330
Loans 90 or More Days Past Due & Still Accruing	0	0
Total	$ 320	330
Home Mortgage
Financing Receivable Recorded Investment Past Due [Line Items]
Nonaccrual		599
Loans 90 or More Days Past Due & Still Accruing		0
Total		$ 599

Loans and Allowance for Loan_10

Loans and Allowance for Loan Losses - Schedule of Aging Analysis of Recorded Investment in Past Due Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	$ 2,047	$ 599
Total Current or Less Than 30 Days Past Due	1,233,898	1,103,509
Total	1,235,945	1,104,108
Commercial Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
Total Current or Less Than 30 Days Past Due	690,391	654,235
Total	690,391	654,235
SBA Loans Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	596	0
Total Current or Less Than 30 Days Past Due	218,906	136,873
Total	219,502	136,873
SBA Loans Non- Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	395	0
Total Current or Less Than 30 Days Past Due	85,249	75,651
Total	85,644	75,651
Commercial and Industrial
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
Total Current or Less Than 30 Days Past Due	123,704	107,505
Total	123,704	107,505
Home Mortgage
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	1,056	599
Total Current or Less Than 30 Days Past Due	114,597	128,084
Total	115,653	128,683
Consumer
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
Total Current or Less Than 30 Days Past Due	1,051	1,161
Total	1,051	1,161
30-59 Days Past Due
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	265	0
30-59 Days Past Due | Commercial Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
30-59 Days Past Due | SBA Loans Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	52	0
30-59 Days Past Due | SBA Loans Non- Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	213	0
30-59 Days Past Due | Commercial and Industrial
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
30-59 Days Past Due | Home Mortgage
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
30-59 Days Past Due | Consumer
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
60-89 Days Past Due
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	1,472	0
60-89 Days Past Due | Commercial Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
60-89 Days Past Due | SBA Loans Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	396	0
60-89 Days Past Due | SBA Loans Non- Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	20	0
60-89 Days Past Due | Commercial and Industrial
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
60-89 Days Past Due | Home Mortgage
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	1,056	0
60-89 Days Past Due | Consumer
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
90 or More Days Pass Due
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	310	599
90 or More Days Pass Due | Commercial Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
90 or More Days Pass Due | SBA Loans Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	148	0
90 or More Days Pass Due | SBA Loans Non- Real Estate
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	162	0
90 or More Days Pass Due | Commercial and Industrial
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	0
90 or More Days Pass Due | Home Mortgage
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	0	599
90 or More Days Pass Due | Consumer
Financing Receivable Recorded Investment Past Due [Line Items]
Past Due Loans	$ 0	$ 0

Loans and Allowance for Loan_11

Loans and Allowance for Loan Losses - Schedule of Loan Deferment Status Change by Loan Type (Details) $ in Thousands	Sep. 30, 2021USD ($)loan	Dec. 31, 2020USD ($)
Financing Receivable Recorded Investment Past Due [Line Items]
Total deferments under the CARES Act, Balance	$ 320	$ 330
Payment resumed or paid off, Balance	1,235,945	1,104,108
Home mortgage loans
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Balance	$ 115,653	$ 128,683
Payment Deferral | Total deferments under the CARES Act
Financing Receivable Recorded Investment Past Due [Line Items]
Total deferments under the CARES Act, Number of accounts | loan	225
Payment resumed or paid off, Balance	$ 250,727
Payment Deferral | Remaining deferments
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Balance	$ 6,748
Remaining deferments, Number of accounts | loan	4
Payment Deferral | payment resumed or paid off
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Number of accounts | loan	221
Payment resumed or paid off, Balance	$ 243,979
Payment Deferral | Loans, excluding home mortgage and consumer loans | Total deferments under the CARES Act
Financing Receivable Recorded Investment Past Due [Line Items]
Total deferments under the CARES Act, Number of accounts | loan	156
Payment resumed or paid off, Balance	$ 220,522
Payment Deferral | Loans, excluding home mortgage and consumer loans | Remaining deferments
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Balance	$ 6,748
Remaining deferments, Number of accounts | loan	4
Payment Deferral | Loans, excluding home mortgage and consumer loans | payment resumed or paid off
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Number of accounts | loan	152
Payment resumed or paid off, Balance	$ 213,774
Payment Deferral | Home mortgage loans | Total deferments under the CARES Act
Financing Receivable Recorded Investment Past Due [Line Items]
Total deferments under the CARES Act, Number of accounts | loan	69
Payment resumed or paid off, Balance	$ 30,205
Payment Deferral | Home mortgage loans | Remaining deferments
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Balance	$ 0
Remaining deferments, Number of accounts | loan	0
Payment Deferral | Home mortgage loans | payment resumed or paid off
Financing Receivable Recorded Investment Past Due [Line Items]
Payment resumed or paid off, Number of accounts | loan	69
Payment resumed or paid off, Balance	$ 30,205

Loans and Allowance for Loan_12

Loans and Allowance for Loan Losses - Schedule of Credit Risk Ratings by Portfolio Segment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable Recorded Investment [Line Items]
Loans	$ 1,235,945	$ 1,104,108
Pass
Financing Receivable Recorded Investment [Line Items]
Loans	1,233,744	1,096,248
Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	535
Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	2,170	7,325
Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	31	0
Commercial Real Estate
Financing Receivable Recorded Investment [Line Items]
Loans	690,391	654,235
Commercial Real Estate | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	690,391	654,235
Commercial Real Estate | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Commercial Real Estate | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Commercial Real Estate | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
SBA Loans Real Estate
Financing Receivable Recorded Investment [Line Items]
Loans	219,502	136,873
SBA Loans Real Estate | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	217,999	134,815
SBA Loans Real Estate | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	535
SBA Loans Real Estate | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	1,503	1,523
SBA Loans Real Estate | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
SBA Loans Non- Real Estate
Financing Receivable Recorded Investment [Line Items]
Loans	85,644	75,651
SBA Loans Non- Real Estate | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	85,266	75,453
SBA Loans Non- Real Estate | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
SBA Loans Non- Real Estate | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	347	198
SBA Loans Non- Real Estate | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	31	0
Commercial and Industrial
Financing Receivable Recorded Investment [Line Items]
Loans	123,704	107,505
Commercial and Industrial | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	123,384	102,500
Commercial and Industrial | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Commercial and Industrial | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	320	5,005
Commercial and Industrial | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Home Mortgage
Financing Receivable Recorded Investment [Line Items]
Loans	115,653	128,683
Home Mortgage | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	115,653	128,084
Home Mortgage | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Home Mortgage | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	0	599
Home Mortgage | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Consumer
Financing Receivable Recorded Investment [Line Items]
Loans	1,051	1,161
Consumer | Pass
Financing Receivable Recorded Investment [Line Items]
Loans	1,051	1,161
Consumer | Special Mention
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Consumer | Substandard
Financing Receivable Recorded Investment [Line Items]
Loans	0	0
Consumer | Doubtful
Financing Receivable Recorded Investment [Line Items]
Loans	$ 0	$ 0

Premises and Equipment - Schedu

Premises and Equipment - Schedule of Premises and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Total cost	$ 13,384	$ 12,778
Accumulated depreciation	(9,185)	(8,234)
Net book value	4,199	4,544
Leasehold improvements
Property Plant And Equipment [Line Items]
Total cost	7,095	6,878
Furniture and fixtures
Property Plant And Equipment [Line Items]
Total cost	3,377	3,307
Equipment and others
Property Plant And Equipment [Line Items]
Total cost	$ 2,912	$ 2,593

Premises and Equipment - Additi

Premises and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 332	$ 326	$ 989	$ 981

Servicing Assets - Additional I

Servicing Assets - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Servicing Assets At Amortized Value [Line Items]
Servicing assets	$ 12,389,000		$ 7,360,000
Valuation allowance for impairment	0		0
Servicing assets	$ 15,138,000	$ 8,800,000	$ 9,106,000
Minimum
Servicing Assets At Amortized Value [Line Items]
Fair value of servicing assets, discount rates	3.80%	5.40%
Fair value of servicing assets, prepayment speed	14.30%	14.50%
Maximum
Servicing Assets At Amortized Value [Line Items]
Fair value of servicing assets, discount rates	10.00%	11.90%
Fair value of servicing assets, prepayment speed	14.70%	14.90%

Servicing Assets - Schedule of

Servicing Assets - Schedule of Changes in Activity for Loan Servicing Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Analysis of Changes in Activity
Beginning balance	$ 12,903	$ 6,972	$ 7,360	$ 7,024
Amortized to expense	(1,047)	(335)	(2,448)	(1,156)
Ending balance	12,389	7,222	12,389	7,222
Loans sold with servicing retained
Analysis of Changes in Activity
Additions	533	585	1,380	1,354
Purchase of servicing rights
Analysis of Changes in Activity
Additions	$ 0	$ 0	$ 6,097	$ 0

Deposits - Additional Informati

Deposits - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Time Deposits [Line Items]
Time deposits greater than $250,000	$ 209,091	$ 200,210
Principal Officers, Directors, and Affiliates
Time Deposits [Line Items]
Deposits from principal officers, directors, and their affiliates	$ 1,800	$ 1,500

Deposits - Schedule of Maturiti

Deposits - Schedule of Maturities of Time Deposits (Details) $ in Thousands	Sep. 30, 2021USD ($)
Deposits [Abstract]
Remainder of 2021	$ 127,429
2022	299,157
2023	3,132
2024	1,387
2025	768
Thereafter	206
Total	$ 432,079

Borrowing Arrangements - Additi

Borrowing Arrangements - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Federal home loan bank borrowings	$ 0	$ 5,000
Interest rate under the Recovery Advance Program to support pandemic relief		0.00%
Letter of credit	67,000	$ 67,000
Collateral pledged	$ 906,300	$ 909,200

Borrowing Arrangements - Summar

Borrowing Arrangements - Summary of Borrowings Available to the Company from Institutions (Details) $ in Thousands	Sep. 30, 2021USD ($)
Debt Disclosure [Line Items]
Amount of borrowings	$ 571,958
Federal Home Loan Bank—San Francisco
Debt Disclosure [Line Items]
Amount of borrowings	333,351
Federal Reserve Bank—San Francisco
Debt Disclosure [Line Items]
Amount of borrowings	138,607
Pacific Coast Bankers Bank
Debt Disclosure [Line Items]
Amount of borrowings	50,000
Zions Bank
Debt Disclosure [Line Items]
Amount of borrowings	25,000
First Horizon Bank
Debt Disclosure [Line Items]
Amount of borrowings	$ 25,000

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 3,246,000	$ 1,459,000	$ 8,054,000	$ 3,594,000
Effective income tax rate	28.20%	28.90%	29.00%	27.90%
Unrealized tax benefits	$ 0	$ 0	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Summary of Distribution of Undisbursed Credit-related Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Undisbursed Credit Related Commitments [Line Items]
Other Commitment	$ 154,160	$ 86,504
Loan commitments
Undisbursed Credit Related Commitments [Line Items]
Other Commitment	147,889	75,740
Standby letters of credits
Undisbursed Credit Related Commitments [Line Items]
Letters of Credit Outstanding, Amount	5,514	9,212
Commercial letters of credit
Undisbursed Credit Related Commitments [Line Items]
Letters of Credit Outstanding, Amount	$ 757	$ 1,552

Commitments and Contingencies_2

Commitments and Contingencies - Investments in Low Income Housing Partnerships, Net and Related Unfunded Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Investments in low-income housing partnerships	$ 8,028	$ 4,932
Unfunded commitments to fund investments for low-income housing partnerships	$ 5,020	$ 2,154

Commitments and Contingencies_3

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Recognized amortization expense of investments in low-income housing partnership	$ 151	$ 107	$ 405	$ 268
Recognized tax credits and other benefits received	$ 190	$ 83	$ 506	$ 230

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2013	Dec. 31, 2012
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation expense	$ 167,000	$ 249,000	$ 403,000	$ 965,000
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation shares authorized under stock option plans (in shares)	770,000		770,000
Percent of the fair value options granted			100.00%
Shares available for future grant (in shares)	0		0
Weighted average remaining contractual term stock options outstanding			1 year 11 months 23 days
Number of options outstanding, Granted (in shares)			0
2005 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			5 years
Stock options, when granted, expiration period			10 years
2010 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation shares authorized under stock option plans (in shares)	0		0		2,500,000	1,350,000
Percent of the fair value options granted			100.00%
Weighted average remaining contractual term stock options outstanding			2 years 6 months
Unrecognized compensation costs related to unvested restricted stock awards	$ 69,000		$ 69,000
Unrecognized compensation costs weighted average period			2 years 5 months 4 days
Number of options outstanding, Granted (in shares)			0
2010 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			5 years
Stock options, when granted, expiration period			10 years
2010 Plan | Restricted Stock Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Tax benefits or expenses realized from awards	$ 0	$ 24,000	$ (85,000)	$ 21,000
2021 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares available for future grant (in shares)	1,323,207		1,323,207
Unrecognized compensation costs related to unvested restricted stock awards	$ 1,600,000		$ 1,600,000
Unrecognized compensation costs weighted average period			3 years 6 months
2021 Plan | Restricted Stock Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation shares authorized under stock option plans (in shares)	1,500,000		1,500,000
Percent of the fair value options granted			100.00%
Number of options outstanding, Granted (in shares)			0
Tax benefits or expenses realized from awards			$ 0

Stock-based Compensation - Summ

Stock-based Compensation - Summary of Stock-based Compensation Stock Options Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
2005 Plan
Stock Option Activity
Number of options outstanding, Beginning of period (in shares) | shares	100,000
Number of options outstanding, Granted (in shares) | shares	0
Number of options outstanding, Exercised (in shares) | shares	(40,000)
Number of options outstanding, Forfeited (in shares) | shares	0
Number of options outstanding, Expired (in shares) | shares	0
Number of options outstanding, Ending of period (in shares) | shares	60,000
Weighted Average Exercise Price
Weighted average exercise price, Outstanding beginning (USD per share) | $ / shares	$ 5.77
Weighted average exercise price, Granted (USD per share) | $ / shares	0
Weighted average exercise price, Exercised (USD per share) | $ / shares	1.60
Weighted average exercise price, Forfeited (USD per share) | $ / shares	0
Weighted average exercise price, Expired (USD per share) | $ / shares	0
Weighted average exercise price, Outstanding ending (USD per share) | $ / shares	$ 6.28
Stock Option Additional Disclosures
Number of options outstanding, Full vested and expected to vest (in shares) | shares	60,000
Number of options outstanding, Vested (in shares) | shares	60,000
Weighted average exercise price, Full vested and expected to vest (USD per share) | $ / shares	$ 6.28
Weighted average exercise price, Vested (USD per share) | $ / shares	$ 6.28
Aggregate intrinsic value, Outstanding | $	$ 241
Aggregate intrinsic value, Fully vested and expected to vest | $	241
Aggregate intrinsic value, Vested | $	$ 241
2010 Plan
Stock Option Activity
Number of options outstanding, Beginning of period (in shares) | shares	220,000
Number of options outstanding, Granted (in shares) | shares	0
Number of options outstanding, Exercised (in shares) | shares	(10,000)
Number of options outstanding, Forfeited (in shares) | shares	0
Number of options outstanding, Expired (in shares) | shares	0
Number of options outstanding, Ending of period (in shares) | shares	210,000
Weighted Average Exercise Price
Weighted average exercise price, Outstanding beginning (USD per share) | $ / shares	$ 7.75
Weighted average exercise price, Granted (USD per share) | $ / shares	0
Weighted average exercise price, Exercised (USD per share) | $ / shares	2.53
Weighted average exercise price, Forfeited (USD per share) | $ / shares	0
Weighted average exercise price, Expired (USD per share) | $ / shares	0
Weighted average exercise price, Outstanding ending (USD per share) | $ / shares	$ 8
Stock Option Additional Disclosures
Number of options outstanding, Full vested and expected to vest (in shares) | shares	210,000
Number of options outstanding, Vested (in shares) | shares	210,000
Weighted average exercise price, Full vested and expected to vest (USD per share) | $ / shares	$ 8
Weighted average exercise price, Vested (USD per share) | $ / shares	$ 8
Aggregate intrinsic value, Outstanding | $	$ 483
Aggregate intrinsic value, Fully vested and expected to vest | $	483
Aggregate intrinsic value, Vested | $	$ 483

Stock-based Compensation - Su_2

Stock-based Compensation - Summary of Information Related to Stock Option Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Cash received from option exercises			$ 89	$ 305
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Intrinsic value of options exercised	$ 0	$ 0	174	370
Cash received from option exercises	0	0	64	63
Tax benefit realized from option exercised	0	0	20	17
2010 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Intrinsic value of options exercised	0	0	86	608
Cash received from option exercises	0	0	25	242
Tax benefit realized from option exercised	0	0	0	157
2010 Plan | Restricted Stock Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Tax benefit (provision) realized from awards vested	$ 0	$ 24	$ (85)	$ 21

Stock-based Compensation - Su_3

Stock-based Compensation - Summary of Changes in Non-vested Restricted Stock Awards (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
2010 Plan
Equity Instruments Other than Options Activity
Shares issued, Awards granted (in shares) | shares	0
Shares issued, Awards forfeited (in shares) | shares	(5,000)
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Awards granted (USD per share) | $ / shares	$ 0
Weighted average grant date fair value, Awards forfeited (USD per share) | $ / shares	$ 9.69
2010 Plan | Restricted Stock Awards
Equity Instruments Other than Options Activity
Shares issued, Non-vested beginning of period (in shares) | shares	154,500
Shares issued, Awards vested (in shares) | shares	(128,500)
Shares issued, Non-vested end of period (in shares) | shares	21,000
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Non-vested beginning of period (USD per share) | $ / shares	$ 11.66
Weighted average grant date fair value, Awards vested (USD per share) | $ / shares	12.34
Weighted average grant date fair value, Non-vested end of period (USD per share) | $ / shares	$ 7.95
Aggregate intrinsic value, Non-vested end of year | $	$ 216
2021 Plan | Restricted Stock Awards
Equity Instruments Other than Options Activity
Shares issued, Non-vested beginning of period (in shares) | shares	0
Shares issued, Awards granted (in shares) | shares	176,793
Shares issued, Awards vested (in shares) | shares	(152)
Shares issued, Awards forfeited (in shares) | shares	0
Shares issued, Non-vested end of period (in shares) | shares	176,641
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Non-vested beginning of period (USD per share) | $ / shares	$ 0
Weighted average grant date fair value, Awards granted (USD per share) | $ / shares	9.90
Weighted average grant date fair value, Awards vested (USD per share) | $ / shares	9.90
Weighted average grant date fair value, Awards forfeited (USD per share) | $ / shares	0
Weighted average grant date fair value, Non-vested end of period (USD per share) | $ / shares	$ 9.90
Aggregate intrinsic value, Non-vested end of year | $	$ 1,819

Employee Benefit Plan - Additio

Employee Benefit Plan - Additional Information (Details) - 401 (k) Plan - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Defined Contribution Plan Disclosure [Line Items]
Employee minimum service period			3 months
Eligibility age of employees for plan			18 years
Employer contribution amount	$ 188	$ 170	$ 557	$ 526

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	$ 102,535	$ 91,791
Other investment securities:
Equity investment in mutual fund with readily determinable fair value	3,700	3,800
U.S. Government-sponsored agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value		1,005
Residential mortgage-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	27,214	19,704
Residential collateralized mortgage obligations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	75,321	71,082
Fair Value, Measurements, Recurring
Other investment securities:
Equity investment in mutual fund with readily determinable fair value	3,734	3,773
Fair Value, Measurements, Recurring | U.S. Government-sponsored agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value		1,005
Fair Value, Measurements, Recurring | Residential mortgage-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	27,214	19,704
Fair Value, Measurements, Recurring | Residential collateralized mortgage obligations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	75,321	71,082
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets (Level 1)
Other investment securities:
Equity investment in mutual fund with readily determinable fair value	3,734	3,773
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets (Level 1) | U.S. Government-sponsored agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value		0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets (Level 1) | Residential mortgage-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets (Level 1) | Residential collateralized mortgage obligations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Other investment securities:
Equity investment in mutual fund with readily determinable fair value	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | U.S. Government-sponsored agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value		1,005
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Residential mortgage-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	27,214	19,704
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Residential collateralized mortgage obligations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	75,321	71,082
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Other investment securities:
Equity investment in mutual fund with readily determinable fair value	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | U.S. Government-sponsored agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value		0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Residential mortgage-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Residential collateralized mortgage obligations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Available-for-sale debt securities, at fair value	$ 0	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Fair Value Hierarchy and Fair Value of Assets That Were Still Held and Had Fair Value Adjustments Measured On a Nonrecurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable Impaired [Line Items]
Impaired loans	$ 1,217,597	$ 1,109,217
Quoted Prices in Active Markets (Level 1)
Financing Receivable Impaired [Line Items]
Impaired loans	0	0
Significant Other Observable Inputs (Level 2)
Financing Receivable Impaired [Line Items]
Impaired loans	0	0
Significant Unobservable Inputs (Level 3)
Financing Receivable Impaired [Line Items]
Impaired loans	1,217,597	1,109,217
Fair Value, Measurements, Nonrecurring
Financing Receivable Impaired [Line Items]
Impaired loans	443	87
Fair Value, Measurements, Nonrecurring | Quoted Prices in Active Markets (Level 1)
Financing Receivable Impaired [Line Items]
Impaired loans	0	0
Fair Value, Measurements, Nonrecurring | Significant Other Observable Inputs (Level 2)
Financing Receivable Impaired [Line Items]
Impaired loans	0	0
Fair Value, Measurements, Nonrecurring | Significant Unobservable Inputs (Level 3)
Financing Receivable Impaired [Line Items]
Impaired loans	$ 443	$ 87

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Summary of Increase (Decrease) In Value of Certain Assets Held at End of Respective Reporting Periods Presented for Which a Nonrecurring Fair Value Adjustment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Measurements, Nonrecurring | Loans Receivable
Financing Receivable Impaired [Line Items]
Impaired loans	$ (106)	$ 0	$ (99)	$ (56)

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Summary of Information about Significant Unobservable Inputs Utilized in Company's Nonrecurring Level 3 Fair Value Measurements (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 1,217,597	$ 1,109,217
Summary of Information about Significant Unobservable Inputs Utilized in Company's Nonrecurring Level 3 Fair Value Measurements	The following table presents information about significant unobservable inputs utilized in the Company’s nonrecurring Level 3 fair value measurements as of September 30, 2021 and December 31, 2020: September 30, 2021 ($ in thousands) Fair Value Valuation Unobservable Range of Weighted- Average of Inputs (1) Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—real estate $ 47 Market approach Market data comparison (13.0)% to 18.0% (0.1)% SBA loans—real estate $ 396 Income approach - income capitalization Capitalization rate 12.0% 12.0% December 31, 2020 Impaired loans: Commercial and industrial (2) $ — Income approach - discounted cash flows Discount rate 3.8% 3.8% SBA loans—non-real estate $ 62 Income approach - discounted cash flows Discount rate 5.3% 5.3% SBA loans—non-real estate $ 25 Market approach Market data comparison (3.5)% to 7.1% 2.9% (1) Weighted-average of inputs is based on the relative fair value of the respective assets as of September 30, 2021 and December 31, 2020. (2) Applying fair value adjustments on the impaired loan through the full specific reserve allowance of the loan carrying value resulted in a zero fair value balance as of September 30, 2021 and December 31, 2020.
Significant Unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 1,217,597	1,109,217
Fair Value, Measurements, Nonrecurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	443	87
Fair Value, Measurements, Nonrecurring | Significant Unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 443	$ 87
Fair Value, Measurements, Nonrecurring | Commercial and Industrial | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	0.038	0.038
Fair Value, Measurements, Nonrecurring | Commercial and Industrial | Weighted Average | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	0.038	0.038
Fair Value, Measurements, Nonrecurring | Commercial and Industrial | Significant Unobservable Inputs (Level 3) | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 0	$ 0
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs		0.053
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Minimum | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs		(0.035)
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Maximum | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs		0.071
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Weighted Average | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs		0.053
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Weighted Average | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs		0.029
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Significant Unobservable Inputs (Level 3) | Valuation Technique, Discounted Cash Flow | Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans		$ 62
Fair Value, Measurements, Nonrecurring | SBA Loans Non- Real Estate | Significant Unobservable Inputs (Level 3) | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans		$ 25
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Valuation Technique Income Approach Income Approach | Capitalization Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	0.120
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Minimum | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	0.130
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Maximum | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	(0.180)
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Weighted Average | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	(0.001)
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Weighted Average | Valuation Technique Income Approach Income Approach | Capitalization Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Measurements Inputs	0.120
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Significant Unobservable Inputs (Level 3) | Valuation, Market Approach | Market Data Comparison
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 47
Fair Value, Measurements, Nonrecurring | SBA Loans Real Estate | Significant Unobservable Inputs (Level 3) | Valuation Technique Income Approach Income Approach | Capitalization Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impaired loans	$ 396

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Carrying Amounts and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Financial Assets:
Cash and cash equivalents	$ 188,145	$ 106,310
Loans held for sale	104,218	26,659
Loans receivable, net	1,217,597	1,109,217
Accrued interest receivable, net	3,931	3,985
Other investments:
Time deposits placed	96	95
Servicing assets	15,138	9,106	$ 8,800
Financial Liabilities:
Deposit	1,497,270	1,200,789
FHLB Advances		5,000
Accrued interest payable	575	1,021
Carrying Amount
Financial Assets:
Cash and cash equivalents	188,145	106,310
Loans held for sale	94,466	26,659
Loans receivable, net	1,217,687	1,084,384
Accrued interest receivable, net	3,931	3,985
Other investments:
FHLB and PCBB stock	7,195	6,233
Time deposits placed	96	95
Servicing assets	12,389	7,360
Financial Liabilities:
Deposit	1,496,406	1,200,090
FHLB Advances		5,000
Accrued interest payable	575	1,021
Level 1
Financial Assets:
Cash and cash equivalents	188,145	106,310
Loans held for sale	0	0
Loans receivable, net	0	0
Accrued interest receivable, net	5	7
Other investments:
Time deposits placed	0	0
Servicing assets	0	0
Financial Liabilities:
Deposit	0	0
FHLB Advances		0
Accrued interest payable	0	0
Level 2
Financial Assets:
Cash and cash equivalents	0	0
Loans held for sale	104,218	26,659
Loans receivable, net	0	0
Accrued interest receivable, net	267	249
Other investments:
Time deposits placed	96	95
Servicing assets	0	0
Financial Liabilities:
Deposit	1,497,270	1,200,789
FHLB Advances		5,000
Accrued interest payable	575	1,021
Level 3
Financial Assets:
Cash and cash equivalents	0	0
Loans held for sale	0	0
Loans receivable, net	1,217,597	1,109,217
Accrued interest receivable, net	3,659	3,729
Other investments:
Time deposits placed	0	0
Servicing assets	15,138	9,106
Financial Liabilities:
Deposit	0	0
FHLB Advances		0
Accrued interest payable	$ 0	$ 0

Regulatory Capital Matters - Ad

Regulatory Capital Matters - Additional Information (Details)	Sep. 30, 2021
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Capital conservation buffer	2.50%

Regulatory Capital Matters - Su

Regulatory Capital Matters - Summary of Actual and Required Capital Amounts and Ratios (Details) $ in Thousands	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items]
Total capital (to risk-weighted assets)	$ 172,873	$ 155,287
Tier 1 capital (to risk-weighted assets)	158,126	142,147
Common equity Tier 1 capital (to risk-weighted assets)	158,126	142,147
Tier 1 leverage (to average assets)	$ 158,126	$ 142,147
Total capital (to risk-weighted assets), ratio	0.1381	0.1481
Tier 1 capital (to risk-weighted assets), ratio	0.1263	0.1356
Common equity Tier 1 capital (to risk-weighted assets), ratio	0.1263	0.1356
Tier 1 leverage (to average assets), ratio	0.0975	0.1055
Bank
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items]
Total capital (to risk-weighted assets)	$ 170,171	$ 152,232
Tier 1 capital (to risk-weighted assets)	155,424	139,092
Common equity Tier 1 capital (to risk-weighted assets)	155,424	139,092
Tier 1 leverage (to average assets)	$ 155,424	$ 139,092
Total capital (to risk-weighted assets), ratio	0.1360	0.1452
Tier 1 capital (to risk-weighted assets), ratio	0.1242	0.1327
Common equity Tier 1 capital (to risk-weighted assets), ratio	0.1242	0.1327
Tier 1 leverage (to average assets), ratio	0.0958	0.1032
Total capital (to risk-weighted assets), amount, Required for Capital Adequacy Purposes	$ 100,135	$ 83,859
Tier 1 capital (to risk-weighted assets), amount, Required for Capital Adequacy Purposes	75,101	62,894
Common equity Tier 1 capital (to risk-weighted assets), amount, Required for Capital Adequacy Purposes	56,326	47,171
Tier 1 leverage (to average assets), amount, Required for Capital Adequacy Purposes	$ 64,875	$ 53,915
Total capital (to risk-weighted assets), ratio, Required for Capital Adequacy Purposes	0.0800	0.0800
Tier 1 capital (to risk-weighted assets), ratio, Required for Capital Adequacy Purposes	0.0600	0.0600
Common equity Tier 1 capital (to risk-weighted assets), ratio, Required for Capital Adequacy Purposes	0.0450	0.0450
Tier 1 leverage (to average assets), ratio, Required for Capital Adequacy Purposes	0.0400	0.0400
Capital required to be well capitalized	$ 125,169	$ 104,824
Tier 1 capital (to risk-weighted assets), amount, Minimum To be Considered "Well Capitalized"	100,135	83,859
Common equity Tier 1 capital (to risk-weighted assets), amount, Minimum To be Considered "Well Capitalized"	81,360	68,136
Tier 1 leverage (to average assets), amount, Minimum To be Considered "Well Capitalized"	$ 81,094	$ 67,393
Total capital (to risk-weighted assets), ratio, Minimum To be Considered "Well Capitalized"	0.1000	0.001000
Tier 1 capital (to risk-weighted assets), ratio, Minimum To be Considered "Well Capitalized"	0.0800	0.000800
Common equity Tier 1 capital (to risk-weighted assets), ratio, Minimum To be Considered "Well Capitalized"	0.0650	0.0650
Tier 1 leverage (to average assets), ratio, Minimum To be Considered "Well Capitalized"	0.0500	0.000500

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Basic
Net income	$ 8,250	$ 3,595	$ 19,706	$ 9,310
Undistributed earnings allocated to participating securities	(109)	(44)	(216)	(154)
Net income allocated to common shares	$ 8,141	$ 3,551	$ 19,490	$ 9,156
Weighted average common shares outstanding (shares)	15,133,407	15,148,833	15,071,327	15,235,617
Basic earnings per common share (in dollars per share)	$ 0.54	$ 0.23	$ 1.29	$ 0.60
Diluted
Net income allocated to common shares	$ 8,141	$ 3,551	$ 19,490	$ 9,156
Weighted average common shares outstanding for basic earnings per common share (shares)	15,133,407	15,148,833	15,071,327	15,235,617
Add: Dilutive effects of assumed exercises of stock options	67,206	33,900	62,246	48,573
Average shares and dilutive potential common shares (shares)	15,200,613	15,182,733	15,133,573	15,284,190
Diluted earnings per common share (in dollars per share)	$ 0.54	$ 0.23	$ 1.29	$ 0.60

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Stock Option
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive shares of common stock excluded from computation of earnings per share (shares)	0	262,000	0	212,000